{"gene":"DKK1","run_date":"2026-06-09T23:54:42","timeline":{"discoveries":[{"year":1999,"finding":"DKK1 is expressed in the Spemann organizer/prechordal plate and functions as a secreted Wnt antagonist; ectopic expression in zebrafish enlarged forebrain, eyes, and axial mesendoderm, and rescued forebrain/notochord defects in bozozok mutants, establishing that Dkk1 acts in dorsal mesendoderm to pattern the anterior nervous system and axial mesendoderm independently of dorso-anterior mesendoderm.","method":"Ectopic expression (mRNA injection), genetic epistasis in zebrafish mutants (boz, sqt, oep), in situ hybridization","journal":"Developmental biology","confidence":"High","confidence_rationale":"Tier 2 / Strong — epistasis across multiple zebrafish mutants, gain-of-function rescue, replicated across multiple genetic backgrounds in one rigorous study","pmids":["10625541"],"is_preprint":false},{"year":1999,"finding":"Dkk-1 is expressed in interdigital mesenchyme during mouse limb development (E9.0–E14.5), with posterior expression initially overlapping Shh, suggesting a role in digit patterning downstream of key limb signaling molecules.","method":"Whole-mount in situ hybridization, double whole-mount in situ hybridization with Shh","journal":"Mechanisms of development","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — detailed expression mapping with spatial co-localization of Dkk1 and Shh, single lab, no loss-of-function","pmids":["10559490"],"is_preprint":false},{"year":2006,"finding":"DKK-1 gene is transcriptionally silenced by CpG island promoter hypermethylation in colon cancer cell lines; treatment with 5-aza-2'-deoxycytidine restored expression. Restoration of DKK-1 in non-expressing cells with truncated APC had no effect on β-catenin/TCF-dependent transcription but induced tumor suppressor-like features (reduced colony formation, tumor growth inhibition in nude mice), indicating DKK-1 functions independently of canonical Wnt signaling in this context.","method":"Bisulfite sequencing/methylation-specific PCR, 5-aza-2'-deoxycytidine demethylation, colony formation assay, nude mouse xenograft, luciferase TCF reporter assay","journal":"Oncogene","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple orthogonal methods (epigenetic, functional in vitro and in vivo) in a single rigorous study","pmids":["16491118"],"is_preprint":false},{"year":2007,"finding":"DKK1 secreted by dermal fibroblasts suppresses melanocyte function and growth by downregulating MITF and β-catenin, and increases keratinocyte proliferation while decreasing melanin uptake; treatment of reconstructed skin with DKK1 induced a thicker, less pigmented epidermis, reproducing the palmoplantar phenotype through Wnt/β-catenin pathway modulation.","method":"Recombinant DKK1 treatment of keratinocytes and reconstructed skin, DNA microarray, RT-PCR, Western blotting","journal":"FASEB journal","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple orthogonal methods (transcriptomics, protein validation, 3D skin model), mechanistically linked to Wnt/β-catenin and MITF regulation","pmids":["17984176"],"is_preprint":false},{"year":2009,"finding":"Dkk-1 inhibits intestinal epithelial cell migration by inducing mislocalized activation of Cdc42, displacing the polarity protein Par6 from the leading edge, and persistently inhibiting relocation of the microtubule organizing center and Golgi apparatus in the direction of migration; siRNA knockdown of Dkk-1 confirmed that extracellular Dkk-1 was required for this polarity defect.","method":"Wound healing assay, recombinant Dkk-1 treatment, siRNA knockdown, immunofluorescence of Cdc42, Par6, MTOC, and Golgi","journal":"Molecular biology of the cell","confidence":"High","confidence_rationale":"Tier 2 / Strong — reciprocal gain/loss-of-function with specific molecular readouts (Cdc42 localization, Par6, MTOC, Golgi) in a single rigorous study","pmids":["19776352"],"is_preprint":false},{"year":2010,"finding":"Neutralization of Dkk-1 in TNF-transgenic mice completely protected from inflammatory bone loss by preventing TNF-mediated impairment of osteoblast function and enhanced osteoclast activity; TNF rapidly increased Dkk-1 expression in primary osteoblasts in vitro, blocking osteoblast differentiation; Dkk-1 blockade also reduced sclerostin expression in differentiated osteoblasts in vitro and in vivo, and reduced osteocyte death.","method":"Anti-Dkk-1 neutralizing antibody in hTNFtg mice, bone histomorphometry, β-catenin/osteocalcin/OPG immunohistochemistry, in vitro primary osteoblast stimulation with TNF","journal":"Annals of the rheumatic diseases","confidence":"High","confidence_rationale":"Tier 2 / Strong — in vivo neutralization combined with in vitro mechanistic follow-up, multiple orthogonal readouts","pmids":["20858621"],"is_preprint":false},{"year":2010,"finding":"Blockade of DKK1 in TNF-transgenic mice reduced bone erosions and osteoclast counts, promoted hypertrophic chondrocyte formation (collagen type X expression), and induced ankylosis of sacroiliac joints, without affecting inflammation; this demonstrates DKK1 normally suppresses Wnt-driven new bone formation in inflammatory joint disease.","method":"Anti-DKK1 antibody treatment in TNFtg mice, histology, immunohistochemistry for collagen X, β-catenin, osteoclast counting","journal":"Annals of the rheumatic diseases","confidence":"High","confidence_rationale":"Tier 2 / Strong — in vivo antibody blockade with multiple histological and molecular readouts","pmids":["19304568"],"is_preprint":false},{"year":2010,"finding":"DKK-1 overexpression in Ace-1 prostate cancer cells increased subcutaneous tumor mass and incidence of bone metastases associated with increased phospho-JNK (non-canonical Wnt pathway), while decreasing the osteoblastic phenotype of bone metastases by inhibiting TCF activity in osteoblast precursors (canonical Wnt pathway).","method":"Stable DKK-1 overexpression, intracardiac/intratibial injection in athymic mice, bioluminescent imaging, micro-CT, histopathology, TCF luciferase assay in ST2 cells, Western blot for phospho-JNK","journal":"The Prostate","confidence":"High","confidence_rationale":"Tier 2 / Strong — in vivo and in vitro with multiple orthogonal mechanistic readouts including pathway-specific reporter and kinase phosphorylation","pmids":["20957670"],"is_preprint":false},{"year":2010,"finding":"Dkk-1 and Dkk-2 redundantly inhibit Wnt signaling to regulate myocardial proliferation during mouse heart development; double null embryos show myocardial hypertrophy with increased cell proliferation and epicardial hypercellularity with broadened Connexin 43 expression from proepicardial precursors.","method":"Double Dkk1/Dkk2 null mouse genetics, histology, immunohistochemistry, BrdU proliferation assay","journal":"International journal of cardiology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic double-null epistasis in mouse, single lab, defined cellular phenotype","pmids":["20439124"],"is_preprint":false},{"year":2012,"finding":"DKK1 overexpression in chondrocytes (Col2a1-Dkk1 transgenic mice or intraarticular AdDkk-1 injection) inhibited DMM-induced experimental osteoarthritis; Wnt-3a-induced expression of Mmp13 and Adamts4 in chondrocytes was blocked by Dkk-1 pretreatment, establishing that Dkk-1 protects cartilage by suppressing Wnt-mediated catabolic factor expression.","method":"Chondrocyte-specific transgenic mice, intraarticular adenoviral injection, OA scoring, recombinant Wnt-3a/Dkk-1 treatment of primary chondrocytes, RT-PCR for Mmp13/Adamts4","journal":"Arthritis and rheumatism","confidence":"High","confidence_rationale":"Tier 2 / Strong — in vivo transgenic and adenoviral gain-of-function with in vitro pathway validation, multiple orthogonal methods","pmids":["22488261"],"is_preprint":false},{"year":2012,"finding":"Dkk-1 in synovial fibroblasts upregulates HIF-1α and angiogenic factors (SDF-1, CSF-1) and proteinases (ADAMTS-5, MMP-3) through stabilization of GSK3β-Ser9, β-catenin, TCF4, and ERK signaling; IL-1β-induced Dkk-1 promotes angiogenesis in endothelial cells. Knockdown of HIF-1α decreased Dkk-1–driven angiogenic factor expression.","method":"Anti-Dkk-1 antibody, siRNA knockdown, IL-1β stimulation, HIF-1α siRNA, ELISA, RT-PCR, in vitro angiogenesis assay, in vivo Dkk-1 antisense oligonucleotide in rat OA","journal":"Arthritis and rheumatism","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple orthogonal methods (antibody neutralization, siRNA, in vivo) with defined molecular pathway","pmids":["22736200"],"is_preprint":false},{"year":2012,"finding":"Osteoblast-specific transcription factor Osterix (Osx) directly binds to two GC-rich sites in the proximal 250 bp of the Dkk1 promoter and activates Dkk1 transcription; Dkk1 expression was downregulated in Osx-null calvaria and after Osx siRNA knockdown, and upregulated upon Osx overexpression.","method":"ChIP-qPCR, promoter deletion luciferase assays, siRNA knockdown, Osx overexpression in Tet-off C2C12 cells, Osx-null embryo calvaria RT-PCR","journal":"Biochemical and biophysical research communications","confidence":"High","confidence_rationale":"Tier 1 / Strong — ChIP combined with promoter deletion mutagenesis and genetic loss-of-function, multiple orthogonal methods","pmids":["22459449"],"is_preprint":false},{"year":2012,"finding":"Kremens (high-affinity DKK1 receptors) internalize DKK1 from the cell surface via clathrin-mediated endocytosis; Kremen1 contains an atypical dileucine motif (DXXXLV) required for internalization, and mutation of LV to AA blocked internalization; AP-2 inhibition or pitstop 2 (clathrin inhibitor) also blocked Kremen1 internalization.","method":"Mutagenesis of Kremen1 dileucine motif, AP-2 siRNA knockdown, clathrin inhibitor pitstop 2, flow cytometry/cell surface assay","journal":"PloS one","confidence":"High","confidence_rationale":"Tier 1 / Moderate — site-directed mutagenesis combined with pharmacological and genetic inhibition, single lab","pmids":["23251700"],"is_preprint":false},{"year":2013,"finding":"DKK1 inhibits tumor angiogenesis and reduces pericyte coverage of tumor blood vessels in B16F10 melanoma-bearing mice, while DKK2 has opposite pro-angiogenic effects; these differential roles were confirmed in endothelial-specific DKK1/DKK2 transgenic mice and in an oxygen-induced retinopathy model.","method":"Adenoviral DKK1/DKK2 expression in tumor-bearing mice, endothelial-specific transgenic mice, tumor vascular density/perfusion quantification, pericyte coverage, oxygen-induced retinopathy model","journal":"Angiogenesis","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple in vivo models (tumor, transgenic, retinopathy) with consistent results","pmids":["24091497"],"is_preprint":false},{"year":2014,"finding":"OTX2 directly activates Dkk1 expression by binding to the H1 regulatory region of Dkk1 in the anterior mesendoderm; tissue-specific ablation of Otx2 in the AME disrupted Dkk1 expression and phenocopied head truncation; compound Otx2;Dkk1 mutants showed enhanced head defects.","method":"Conditional Otx2 knockout, ChIP-qPCR, RT-qPCR, luciferase reporter assay, cross-species comparative analysis, genetic epistasis (compound mutants)","journal":"Development (Cambridge, England)","confidence":"High","confidence_rationale":"Tier 1 / Strong — ChIP validation of direct binding, luciferase reporter, genetic epistasis in compound mutants","pmids":["25231759"],"is_preprint":false},{"year":2014,"finding":"Dkk-1 overexpression in bone (Col1a1-Dkk1 transgenic mice) ameliorated OA severity after meniscectomy by reducing subchondral bone Wnt/β-catenin activation, decreasing VEGF in osteoblasts, and thereby reducing MMP expression in chondrocytes; direct cartilage exposure to Dkk-1 caused proteoglycan loss and increased NITEGE expression, indicating distinct bone-mediated vs. direct cartilage effects.","method":"Col1a1-Dkk1 transgenic mice, meniscectomy OA model, X-Gal staining (Topgal reporter), micro-CT, histomorphometry, cartilage explant culture, VEGF/MMP mRNA analysis","journal":"Arthritis & rheumatology (Hoboken, N.J.)","confidence":"High","confidence_rationale":"Tier 2 / Strong — in vivo transgenic with Wnt reporter, multiple downstream pathway measurements, and orthogonal in vitro validation","pmids":["25080367"],"is_preprint":false},{"year":2014,"finding":"DKK-1 interacts with carbonic anhydrase IX (CA9) via the Val60-Tyr168 site of DKK-1 binding to the N-terminal domain of CA9 in vitro and in vivo; DKK-1 overexpression inhibited CA9-mediated mTOR phosphorylation and endothelial cell angiogenesis in tumorigenesis.","method":"Co-immunoprecipitation, domain mapping, mTOR phosphorylation assay, endothelial cell angiogenesis assay","journal":"Cellular signalling","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — binding domain mapping by co-IP with functional downstream readout, single lab","pmids":["22430125"],"is_preprint":false},{"year":2014,"finding":"Dkk1 expression in peri-cloacal mesenchyme regulates anorectal and genitourinary tract formation; conditional Dkk1 deletion causes imperforate anus with rectourinary fistula and preputial hypospadias, associated with ectopic expansion of dorsal peri-cloacal mesenchyme (increased proliferation/survival) and elevated Wnt/β-catenin, Shh, Fgf8, and Bmp4 activity; genetic hyperactivation of Wnt/β-catenin in cloacal mesenchyme partially recapitulates Dkk1 mutant phenotypes.","method":"Conditional Dkk1 knockout mouse, β-catenin activation transgenic epistasis, histology, immunohistochemistry, BrdU proliferation assay","journal":"Developmental biology","confidence":"High","confidence_rationale":"Tier 2 / Strong — conditional KO with epistasis via Wnt gain-of-function, multiple cellular and molecular phenotypes","pmids":["24479159"],"is_preprint":false},{"year":2014,"finding":"ox-LDL induces DKK1 expression in macrophages; DKK1 in turn decreases LOX-1 via Wnt/β-catenin pathway and increases ABCA/G1 via STAT3 pathway, thereby inhibiting cholesterol loading in macrophages.","method":"ox-LDL stimulation of macrophages, Western blot for LOX-1/ABCA1/ABCG1/β-catenin, STAT3 pathway analysis","journal":"FEBS letters","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — in vitro pathway analysis with downstream targets, single lab, no direct DKK1 gain/loss-of-function","pmids":["25436422"],"is_preprint":false},{"year":2014,"finding":"CBX7 inhibits Wnt/β-catenin/TCF pathway by enhancing DKK-1 transcription through cooperation with p300 acetyltransferase, increasing histone acetylation at the DKK-1 promoter; pharmacologic DKK-1 inhibition in CBX7-overexpressing cells restored Wnt signaling and the CD44+/CD24−/ESA+ stem cell population.","method":"ChIP for histone acetylation at DKK-1 promoter, co-IP of CBX7 with p300, luciferase reporter, DKK-1 pharmacological inhibition, flow cytometry for stem cell markers","journal":"FASEB journal","confidence":"High","confidence_rationale":"Tier 1-2 / Moderate — ChIP showing histone acetylation, Co-IP of the CBX7-p300 complex, functional DKK-1 inhibition rescue, single lab","pmids":["25351982"],"is_preprint":false},{"year":2015,"finding":"TNF strongly induces DKK-1 production in fibroblast-like synoviocytes, whereas IL-6 suppresses DKK-1 production and abrogates TNF-induced DKK-1 upregulation; the inverse correlation between DKK-1 and IL-6 levels in synovial fluid was confirmed in vitro in FLS cultures.","method":"FLS cell culture stimulation with TNF/IL-1β/IL-6, ELISA for DKK-1, correlation analysis in synovial fluid samples","journal":"Arthritis & rheumatology (Hoboken, N.J.)","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — in vitro cytokine regulation confirmed by in vivo correlation, single lab","pmids":["25941031"],"is_preprint":false},{"year":2016,"finding":"Stroma-derived DKK1 targets β-catenin in MDSCs to suppress their immune function and promote tumor growth; DKK1 neutralization decreases MDSC numbers by rescuing β-catenin; recombinant DKK1 suppressed β-catenin target genes in MDSCs from mice and humans; anti-DKK1 antitumor effects were lost in mice lacking β-catenin in myeloid cells or after MDSC depletion.","method":"DKK1 neutralizing antibody in tumor-bearing mice, myeloid-specific β-catenin conditional knockout epistasis, MDSC depletion, recombinant DKK1 treatment, flow cytometry, gene expression analysis","journal":"The Journal of experimental medicine","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple orthogonal approaches including conditional KO epistasis, antibody neutralization, and recombinant protein, validated in both mouse and human cells","pmids":["27045006"],"is_preprint":false},{"year":2018,"finding":"Conditional deletion of Dkk1 from bone has negligible effects on bone mass unless sclerostin (Sost) is also removed; Dkk1 inhibition increases Sost expression as a compensatory mechanism. Combined deletion of Dkk1 and Sost, or co-administration of anti-Dkk1 and anti-sclerostin antibodies, produced synergistic anabolic bone gain exceeding individual or additive effects.","method":"Conditional Dkk1 bone-specific knockout, Sost osteocyte-specific knockout epistasis, sclerostin neutralizing antibody, DXA, μCT, histomorphometry, biomechanical testing","journal":"JCI insight","confidence":"High","confidence_rationale":"Tier 2 / Strong — conditional double KO genetic epistasis validated by antibody co-treatment, multiple bone measurement modalities","pmids":["29875318"],"is_preprint":false},{"year":2018,"finding":"Atorvastatin downregulates DKK-1 protein and mRNA through inhibition of Cdc42, Rho, and Rac geranylgeranylated proteins; DKK-1 itself mediates ~21% of statin-modulated proteins in endothelial cells, including clusterin/apoJ, PAI-1, MARCKS, and PTX3, establishing DKK-1 as a downstream effector of statin action.","method":"Label-free quantitative mass spectrometry proteomics, DKK-1 siRNA gene silencing, mRNA quantification, statin treatment ± geranylgeranyl pathway inhibitors, in vivo rabbit model","journal":"Scientific reports","confidence":"High","confidence_rationale":"Tier 2 / Strong — proteomics combined with gene silencing and in vivo validation, multiple orthogonal methods","pmids":["30420710"],"is_preprint":false},{"year":2019,"finding":"Osteocyte-specific deletion of Dkk-1 prevented alveolar bone loss in experimental periodontitis in mice, increasing bone volume/density, reducing osteoclast numbers, increasing bone formation markers (Runx2, Osteocalcin), decreasing RANKL expression, and reducing local inflammatory infiltrates; serum Dkk-1 was reduced and TCF-7 expression increased in these mice.","method":"Dkk-1fl/fl;Dmp1:Cre osteocyte-specific conditional knockout, experimental periodontitis ligature model, micro-CT, histomorphometry, RT-PCR, ELISA for Dkk-1/CTX/P1NP","journal":"Frontiers in immunology","confidence":"High","confidence_rationale":"Tier 2 / Strong — cell-type-specific conditional knockout in disease model with multiple in vivo molecular and structural readouts","pmids":["31921182"],"is_preprint":false},{"year":2019,"finding":"DKK1 knockdown in OE33 esophageal adenocarcinoma cells attenuated viability, proliferation, migration, and invasion; these effects were not mediated through the canonical β-catenin pathway but through downstream Akt phosphorylation; Wnt3a restored Akt phosphorylation in DKK1-depleted cells without further stimulating β-catenin transcription, indicating a Wnt-axis-independent oncogenic role for DKK1 via Akt.","method":"siRNA DKK1 knockdown, recombinant DKK1/Wnt3a treatment, Akt phosphorylation Western blot, β-catenin reporter assay, proliferation/migration/invasion assays","journal":"American journal of cancer research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — siRNA and recombinant protein treatments with specific pathway readouts, single lab","pmids":["30906632"],"is_preprint":false},{"year":2019,"finding":"DKK1 promotes invasion and migration of hepatocellular carcinoma cells through a TGF-β1–dependent mechanism; knockdown of TGF-β1 negatively affected the DKK1 proinvasive effect; the canonical Wnt/β-catenin pathway was not responsible for the proinvasive effect as active β-catenin levels were unchanged upon DKK1 treatment.","method":"Recombinant DKK1 treatment, DKK1 siRNA knockdown, TGF-β1 siRNA knockdown, Boyden chamber invasion assay, zymography, MMP-2/MMP-9 Western blot, ELISA","journal":"PloS one","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — reciprocal knockdown of DKK1 and TGF-β1 with functional assays, single lab","pmids":["31568519"],"is_preprint":false},{"year":2020,"finding":"EGF receptor activation promotes DKK1 transcription in HCC via parallel MEK-ERK and PI3K-Akt pathways: ERK phosphorylates PKM2 at Ser37 promoting its nuclear translocation, and Akt phosphorylates p300 at Ser1834; nuclear PKM2 and p300 then cooperatively mediate phosphorylation and acetylation of histone H3 at the DKK1 promoter to synergistically enhance DKK1 transcription.","method":"Mutational analysis of PKM2-Ser37 and p300-Ser1834, nuclear fractionation, ChIP for histone H3 phosphorylation/acetylation at DKK1 promoter, MEK/PI3K inhibition, chemically-induced HCC rat model","journal":"Science signaling","confidence":"High","confidence_rationale":"Tier 1 / Strong — site-directed mutagenesis of two kinase substrates combined with ChIP and in vivo validation, multiple orthogonal methods","pmids":["33172955"],"is_preprint":false},{"year":2020,"finding":"1,25-dihydroxyvitamin D3 (1,25D3) promotes DKK1 expression in osteoblasts by inducing C/EBPβ, which directly binds the human DKK1 promoter; 1,25D3 also stimulates secretion of DKK1 from the endoplasmic reticulum to the extracellular space; blocking DKK1 attenuated calcified nodule formation in mineralized osteoblasts without affecting ALP activity or collagen synthesis, establishing a required role for DKK1 in osteoblast mineralization.","method":"C/EBPβ siRNA knockdown and overexpression, ChIP for C/EBPβ at DKK1 promoter, 1,25D3 treatment, DKK1 secretion/ER trafficking assay, DKK1 blocking antibody in mineralization assay","journal":"Cells","confidence":"High","confidence_rationale":"Tier 1-2 / Strong — ChIP of transcription factor at DKK1 promoter, complementary knockdown/overexpression, functional blocking experiment, single lab with multiple orthogonal methods","pmids":["31963554"],"is_preprint":false},{"year":2021,"finding":"Under hypoxia, p38 kinase phosphorylates CREB driving its nuclear import to activate DKK1 transcription in myeloma cells; CREB recruits MMSET (a downstream target of HIF-1α induced by hypoxia), stabilizing HIF-1α protein and increasing H3K36me2 at the DKK1 promoter; combined CREB inhibition and hypoxia-activated prodrug reduced MM-induced bone destruction in vivo.","method":"p38 inhibition, CREB knockdown, MMSET knockdown, ChIP for H3K36me2 at DKK1 promoter, nuclear import assay, in vivo MM bone destruction model","journal":"Oncogene","confidence":"High","confidence_rationale":"Tier 1-2 / Strong — ChIP for specific histone mark at DKK1 promoter, kinase pathway inhibition, genetic knockdowns with in vivo validation","pmids":["33420361"],"is_preprint":false},{"year":2021,"finding":"DKK1 suppresses WWP2 (an E3 ubiquitin ligase) expression via canonical Wnt/β-catenin signaling; loss of WWP2 stabilizes GLI2 (a Hedgehog transcription factor) by preventing its ubiquitination and proteasomal degradation, thereby activating Hedgehog signaling and promoting bortezomib resistance in multiple myeloma cells.","method":"WWP2 knockdown and overexpression, DKK1 manipulation, GLI2 ubiquitination assay, Hh pathway reporter, in vitro and in vivo bortezomib resistance assays","journal":"Carcinogenesis","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ubiquitination assay combined with pathway-specific reporters and in vivo validation, single lab","pmids":["34546340"],"is_preprint":false},{"year":2022,"finding":"hAMSC-derived DKK-1 (along with IGFBP-3 and DKK-3) inhibits hepatic stellate cell activation by blocking the canonical Wnt/β-catenin signaling pathway; siRNA silencing of DKK-1 in hAMSCs reversed this inhibitory effect, attenuating the anti-fibrotic action; this was confirmed via GSK3β/β-catenin pathway assessment.","method":"hAMSC transplantation in CCl4-induced liver fibrosis mice, antibody array for secreted cytokines, siRNA knockdown of DKK-1/DKK-3/IGFBP-3, Western blot for Wnt/β-catenin components","journal":"Stem cell research & therapy","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — secretome array combined with siRNA epistasis validation in vitro and in vivo, single lab","pmids":["35659360"],"is_preprint":false},{"year":2023,"finding":"DKK1 binding to CKAP4 is required for HCC cell proliferation; DKK1 lacking the CKAP4 binding region did not rescue phenotypes caused by DKK1 depletion; deletion of either DKK1 or CKAP4 inhibited HCC cell growth; anti-CKAP4 antibody inhibited HCC growth and showed enhanced antitumor effect when combined with lenvatinib.","method":"DKK1/CKAP4 deletion in HCC cells, domain-deletion rescue experiment, anti-CKAP4 antibody treatment, in vivo HCC tumor growth assay, co-treatment with lenvatinib","journal":"Cancer science","confidence":"High","confidence_rationale":"Tier 2 / Strong — domain-deletion rescue experiment establishes binding requirement, complemented by in vivo antibody experiments","pmids":["36718957"],"is_preprint":false},{"year":2023,"finding":"DKK1 in prostate cancer cells promotes growth and migration independently of canonical Wnt signaling via upregulation of NF-κB/p65 signaling, inhibition of caspase-dependent apoptosis through downregulation of non-canonical Wnt/JNK signaling, and upregulation of EMT genes; DKK1 also inhibits osteoblast differentiation and promotes osteoclast activity by decreasing the OPG/RANKL ratio in the bone microenvironment.","method":"Stable DKK1 transduction in Probasco PCa cells, intratibial/intracardiac injection in nude mice, in vitro proliferation/migration assays, NF-κB/p65 and caspase Western blot, primary osteoblast/osteoclast co-culture assays, OPG/RANKL measurement","journal":"Cells","confidence":"High","confidence_rationale":"Tier 2 / Strong — in vivo and in vitro with multiple signaling pathway readouts and bone cell functional assays","pmids":["38067123"],"is_preprint":false},{"year":2023,"finding":"NR2F2 silencing in endothelial cells induces DKK1 production; co-silencing DKK1 and NR2F2 prevents NR2F2-loss-induced STAT and AKT activation and reverses endothelial-to-mesenchymal transition, establishing DKK1 as a downstream effector of NR2F2 loss that drives pathologic endothelial signaling.","method":"NR2F2 siRNA silencing, co-silencing of NR2F2 and DKK1, STAT/AKT phosphorylation Western blot, EndMT marker analysis, serum DKK1 ELISA in PAH patients","journal":"American journal of physiology. Lung cellular and molecular physiology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — co-silencing epistasis with multiple molecular readouts, single lab","pmids":["37039367"],"is_preprint":false},{"year":2024,"finding":"DKK1 loss in endometrial stromal cells promotes endometrial fibrosis by suppressing autophagic flux through Wnt/β-catenin and PI3K/AKT/mTOR pathways, and by promoting secretion of IL-8 in exosomes that drives macrophage proliferation and macrophage-to-myofibroblast transition; rapamycin partially restored the fibrotic phenotype in DKK1 conditional knockout mice.","method":"DKK1 conditional knockout mice, DKK1 siRNA/overexpression in endometrial stromal cells, autophagic flux assay, exosome IL-8 measurement, rapamycin rescue experiment, immunohistochemistry for α-SMA/macrophages","journal":"Journal of translational medicine","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — conditional KO with in vitro mechanistic follow-up, rapamycin epistasis, single lab","pmids":["38961399"],"is_preprint":false}],"current_model":"DKK1 is a secreted glycoprotein that functions primarily as a canonical Wnt inhibitor by competing with Wnt ligands for binding to LRP5/6 co-receptors (facilitated by Kremen1/2 high-affinity receptors that internalize via clathrin-mediated endocytosis), thereby suppressing β-catenin/TCF transcription; its expression is directly activated by transcription factors OTX2 and Osterix at defined promoter elements, induced epigenetically by EGFR-driven PKM2/p300-mediated H3 phospho-acetylation and by hypoxia-driven CREB/MMSET H3K36me2, and repressed by CpG methylation; beyond canonical Wnt inhibition, DKK1 signals through a β-catenin-independent CKAP4 receptor to drive cancer cell proliferation, through AKT phosphorylation to promote tumor growth, via TGF-β1 to promote invasion, and through NF-κB/non-canonical Wnt/JNK to inhibit apoptosis; in bone, DKK1 from osteoblasts/osteocytes suppresses osteoblastogenesis while promoting osteoclast activity, and its upregulation by Sost/sclerostin constitutes a compensatory mechanism limiting Wnt-driven bone anabolism; in the immune microenvironment, stroma-derived DKK1 suppresses β-catenin in MDSCs to drive immune suppression, while in epithelial tissues DKK1 disrupts directional cell polarity by mislocalizing Cdc42 and displacing Par6 from the leading edge."},"narrative":{"mechanistic_narrative":"DKK1 is a secreted glycoprotein that acts as a context-dependent antagonist of canonical Wnt/β-catenin signaling, patterning embryonic axes and tuning Wnt output in bone, cartilage, vasculature, immune cells, and epithelia [PMID:10625541, PMID:20858621, PMID:25080367]. In development it is expressed in the Spemann organizer and prechordal plate, where its secreted Wnt-antagonist activity patterns the anterior nervous system and axial mesendoderm; this expression is driven directly by OTX2 binding the H1 regulatory region and is required, together with Wnt restraint, for anterior head and peri-cloacal anorectal/genitourinary morphogenesis [PMID:10625541, PMID:25231759, PMID:24479159]. High-affinity Kremen receptors clear DKK1 from the cell surface through clathrin- and AP-2-dependent endocytosis governed by an atypical Kremen1 dileucine motif [PMID:23251700]. In bone, osteoblast/osteocyte-derived DKK1 suppresses Wnt-driven osteoblast differentiation and new bone formation while promoting osteoclast activity, and its conditional loss is buffered by compensatory upregulation of sclerostin, such that combined Dkk1/Sost ablation yields synergistic anabolic bone gain; this axis underlies inflammatory bone erosion, periodontal bone loss, and protection of cartilage in osteoarthritis [PMID:20858621, PMID:19304568, PMID:29875318, PMID:31921182, PMID:25080367]. DKK1 transcription is regulated by Osterix and C/EBPβ at the proximal promoter, by epigenetic activation through CBX7/p300 histone acetylation, EGFR-driven nuclear PKM2/p300-mediated H3 phospho-acetylation, and hypoxia-driven CREB/MMSET H3K36me2, and is silenced by CpG promoter hypermethylation in colon cancer [PMID:22459449, PMID:31963554, PMID:25351982, PMID:33172955, PMID:33420361, PMID:16491118]. Beyond canonical Wnt inhibition, DKK1 drives β-catenin-independent oncogenic signaling: it binds CKAP4 to sustain hepatocellular carcinoma proliferation, signals through AKT and TGF-β1 to promote tumor growth and invasion, and through NF-κB and non-canonical Wnt/JNK to promote prostate cancer growth and suppress apoptosis [PMID:36718957, PMID:30906632, PMID:31568519, PMID:38067123]. In the tumor microenvironment, stroma-derived DKK1 suppresses β-catenin in myeloid-derived suppressor cells to enforce immune suppression, and in migrating epithelial cells it disrupts directional polarity by mislocalizing Cdc42 and displacing Par6 from the leading edge [PMID:27045006, PMID:19776352].","teleology":[{"year":1999,"claim":"Establishing DKK1 as a secreted Wnt antagonist that patterns the anterior nervous system answered what its core embryonic activity is and where it acts.","evidence":"Ectopic mRNA expression and genetic epistasis across zebrafish mutants with in situ hybridization","pmids":["10625541"],"confidence":"High","gaps":["Receptor identity at the time undefined","Did not address mammalian organogenesis roles"]},{"year":2006,"claim":"Discovery of CpG promoter hypermethylation silencing DKK1 in colon cancer, with Wnt-independent tumor-suppressor effects upon re-expression, revealed both an epigenetic control mode and a β-catenin-independent function.","evidence":"Methylation-specific PCR, demethylation, colony/xenograft assays and TCF reporter in colon cancer lines","pmids":["16491118"],"confidence":"High","gaps":["Mechanism of Wnt-independent suppression not defined","Receptor mediating the effect unknown"]},{"year":2009,"claim":"Linking extracellular DKK1 to mislocalized Cdc42 and Par6 displacement explained how it disrupts directional epithelial cell migration.","evidence":"Wound healing with reciprocal recombinant treatment/siRNA and immunofluorescence of polarity machinery in intestinal epithelial cells","pmids":["19776352"],"confidence":"High","gaps":["Receptor coupling DKK1 to Cdc42 not identified","Relationship to canonical Wnt not resolved"]},{"year":2010,"claim":"In vivo neutralization in inflammatory and metastatic models established DKK1 as a driver of pathological bone remodeling acting on both osteoblasts and osteoclasts, and through canonical and non-canonical (JNK) Wnt arms.","evidence":"Anti-Dkk-1 antibody in TNFtg mice, prostate cancer bone metastasis models, histomorphometry, TCF reporter, phospho-JNK blots","pmids":["20858621","19304568","20957670"],"confidence":"High","gaps":["Cell-intrinsic vs paracrine contributions not separated","Direct receptors in osteoclast lineage unclear"]},{"year":2012,"claim":"Identifying Osterix as a direct activator and Kremen-mediated clathrin endocytosis defined transcriptional control and surface clearance of DKK1.","evidence":"ChIP, promoter deletion luciferase, Osx-null calvaria; Kremen1 dileucine mutagenesis with AP-2 siRNA and pitstop 2","pmids":["22459449","23251700"],"confidence":"High","gaps":["How endocytosis quantitatively tunes Wnt inhibition unclear","Other promoter inputs not mapped"]},{"year":2012,"claim":"Demonstrating DKK1 protection of cartilage and angiogenic regulation expanded its role into joint disease and vascular biology.","evidence":"Chondrocyte transgenic/adenoviral OA models with Wnt-3a catabolic gene assays; synovial fibroblast HIF-1α/angiogenic axis and tumor vascular models","pmids":["22488261","22736200","24091497"],"confidence":"High","gaps":["Context-dependent pro- vs anti-angiogenic switch mechanism unclear","Distinct from DKK2 opposing role unexplained"]},{"year":2014,"claim":"OTX2 binding the H1 element and conditional Dkk1 deletion in peri-cloacal mesenchyme established direct upstream control and a developmental requirement in head and anorectal/genitourinary morphogenesis.","evidence":"Conditional Otx2/Dkk1 knockouts, ChIP, luciferase, compound-mutant epistasis, BrdU proliferation","pmids":["25231759","24479159"],"confidence":"High","gaps":["Cross-tissue generalization of OTX2 control untested","Other transcriptional inputs in non-neural tissues unmapped"]},{"year":2014,"claim":"Identifying CBX7/p300 histone acetylation as a DKK1 activator and CA9 as a binding partner broadened the regulatory and interaction landscape.","evidence":"ChIP for promoter acetylation, CBX7-p300 co-IP, stem-cell marker rescue; CA9 co-IP and domain mapping with mTOR/angiogenesis readouts","pmids":["25351982","22430125"],"confidence":"Medium","gaps":["CA9 interaction is single-lab without reciprocal validation in vivo","Physiological significance of CA9 binding unclear"]},{"year":2016,"claim":"Showing stroma-derived DKK1 suppresses β-catenin in MDSCs answered how it contributes to tumor immune suppression beyond tumor-cell-autonomous effects.","evidence":"Antibody neutralization, myeloid β-catenin conditional KO epistasis, MDSC depletion, recombinant DKK1 in mouse and human cells","pmids":["27045006"],"confidence":"High","gaps":["Receptor on MDSCs not identified","Breadth across tumor types not established"]},{"year":2018,"claim":"Conditional Dkk1/Sost double deletion revealed sclerostin as the compensatory mechanism limiting the bone phenotype of DKK1 loss, explaining why single inhibition is buffered.","evidence":"Bone-specific Dkk1 KO, Sost KO epistasis, dual antibody co-treatment, μCT/DXA/biomechanics","pmids":["29875318"],"confidence":"High","gaps":["Molecular basis of Sost upregulation upon DKK1 loss undefined"]},{"year":2019,"claim":"Dissection of Wnt-axis-independent oncogenic signaling through AKT and TGF-β1 clarified how DKK1 promotes proliferation and invasion without engaging β-catenin.","evidence":"siRNA knockdown and recombinant treatment in esophageal and hepatocellular carcinoma cells with AKT/β-catenin and TGF-β1 reciprocal readouts","pmids":["30906632","31568519"],"confidence":"Medium","gaps":["Receptor linking DKK1 to AKT/TGF-β1 not resolved in these studies","Single-lab, single-line findings"]},{"year":2020,"claim":"Mapping EGFR-driven nuclear PKM2/p300 H3 phospho-acetylation and C/EBPβ induction defined signal-responsive transcriptional activation of DKK1.","evidence":"Site-directed mutagenesis of PKM2-Ser37/p300-Ser1834, ChIP at DKK1 promoter, in vivo HCC; C/EBPβ ChIP and 1,25D3 secretion/mineralization assays","pmids":["33172955","31963554"],"confidence":"High","gaps":["Integration of multiple promoter inputs in vivo unclear","Cell-type specificity of each pathway not delineated"]},{"year":2021,"claim":"Hypoxia-driven CREB/MMSET H3K36me2 and DKK1-WWP2-GLI2 crosstalk linked DKK1 induction and downstream Hedgehog activation to myeloma bone disease and drug resistance.","evidence":"p38/CREB/MMSET knockdown, ChIP for H3K36me2; WWP2/GLI2 ubiquitination assays and bortezomib resistance models","pmids":["33420361","34546340"],"confidence":"Medium","gaps":["WWP2-GLI2 axis single-lab without independent confirmation","Generalizability beyond myeloma untested"]},{"year":2023,"claim":"Identifying CKAP4 as a required receptor for DKK1-driven HCC proliferation and NF-κB/JNK signaling in prostate cancer pinned down β-catenin-independent receptor mechanisms.","evidence":"DKK1/CKAP4 deletion and domain-deletion rescue, anti-CKAP4 antibody with lenvatinib; prostate cancer DKK1 transduction with NF-κB/caspase and OPG/RANKL assays","pmids":["36718957","38067123"],"confidence":"High","gaps":["Whether CKAP4 mediates AKT/TGF-β1 effects in other tumors untested","Structural basis of receptor selectivity unclear"]},{"year":2024,"claim":"Defining DKK1 loss as a driver of endometrial fibrosis via autophagy suppression and exosomal IL-8 extended its role into tissue fibrosis and stromal-immune crosstalk.","evidence":"DKK1 conditional KO mice, stromal cell siRNA/overexpression, autophagic flux and exosome IL-8 assays, rapamycin rescue","pmids":["38961399"],"confidence":"Medium","gaps":["Single-lab study","Receptor/pathway selectivity in stromal cells not fully resolved"]},{"year":null,"claim":"The receptor logic distinguishing canonical Wnt-inhibitory DKK1 (via LRP5/6-Kremen) from β-catenin-independent signaling (CKAP4, AKT, NF-κB/JNK, TGF-β1) and how cells select between these outputs remains unresolved.","evidence":"","pmids":[],"confidence":"Low","gaps":["No unifying model linking receptor engagement to downstream pathway choice","Structural determinants of partner selection not defined"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[0,5,15]},{"term_id":"GO:0048018","term_label":"receptor ligand activity","supporting_discovery_ids":[32,16]}],"localization":[{"term_id":"GO:0005576","term_label":"extracellular region","supporting_discovery_ids":[0,4,28]},{"term_id":"GO:0005783","term_label":"endoplasmic reticulum","supporting_discovery_ids":[28]}],"pathway":[{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[0,7,33]},{"term_id":"R-HSA-1266738","term_label":"Developmental Biology","supporting_discovery_ids":[0,14,17]},{"term_id":"R-HSA-1643685","term_label":"Disease","supporting_discovery_ids":[2,21,32]},{"term_id":"R-HSA-168256","term_label":"Immune System","supporting_discovery_ids":[21]},{"term_id":"R-HSA-74160","term_label":"Gene expression (Transcription)","supporting_discovery_ids":[11,14,27,28,29]}],"complexes":[],"partners":["LRP5","LRP6","KREMEN1","CKAP4","CA9"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"O94907","full_name":"Dickkopf-related protein 1","aliases":["SK"],"length_aa":266,"mass_kda":28.7,"function":"Antagonizes canonical Wnt signaling by inhibiting LRP5/6 interaction with Wnt and by forming a ternary complex with the transmembrane protein KREMEN that promotes internalization of LRP5/6 (PubMed:22000856). DKKs play an important role in vertebrate development, where they locally inhibit Wnt regulated processes such as antero-posterior axial patterning, limb development, somitogenesis and eye formation. In the adult, Dkks are implicated in bone formation and bone disease, cancer and Alzheimer disease (PubMed:17143291). Inhibits the pro-apoptotic function of KREMEN1 in a Wnt-independent manner, and has anti-apoptotic activity (By similarity)","subcellular_location":"Secreted","url":"https://www.uniprot.org/uniprotkb/O94907/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/DKK1","classification":"Not Classified","n_dependent_lines":8,"n_total_lines":1208,"dependency_fraction":0.006622516556291391},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/DKK1","total_profiled":1310},"omim":[{"mim_id":"620079","title":"LONG INTERGENIC NONCODING RNA 467; LINC00467","url":"https://www.omim.org/entry/620079"},{"mim_id":"618595","title":"CYTOSKELETON-ASSOCIATED PROTEIN 4; CKAP4","url":"https://www.omim.org/entry/618595"},{"mim_id":"613303","title":"AlkB HOMOLOG 5, RNA DEMETHYLASE; ALKBH5","url":"https://www.omim.org/entry/613303"},{"mim_id":"611731","title":"APC REGULATOR OF WNT SIGNALING PATHWAY; APC","url":"https://www.omim.org/entry/611731"},{"mim_id":"611229","title":"ENDOPLASMIC RETICULUM LECTIN 1; ERLEC1","url":"https://www.omim.org/entry/611229"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"","locations":[],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in many","driving_tissues":[{"tissue":"adipose tissue","ntpm":20.7},{"tissue":"cervix","ntpm":31.9},{"tissue":"placenta","ntpm":46.0}],"url":"https://www.proteinatlas.org/search/DKK1"},"hgnc":{"alias_symbol":["SK","DKK-1"],"prev_symbol":[]},"alphafold":{"accession":"O94907","domains":[{"cath_id":"-","chopping":"94-139","consensus_level":"high","plddt":88.1891,"start":94,"end":139},{"cath_id":"2.10.80.10","chopping":"188-251_258-264","consensus_level":"medium","plddt":89.5642,"start":188,"end":264}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/O94907","model_url":"https://alphafold.ebi.ac.uk/files/AF-O94907-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-O94907-F1-predicted_aligned_error_v6.png","plddt_mean":69.94},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=DKK1","jax_strain_url":"https://www.jax.org/strain/search?query=DKK1"},"sequence":{"accession":"O94907","fasta_url":"https://rest.uniprot.org/uniprotkb/O94907.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/O94907/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/O94907"}},"corpus_meta":[{"pmid":"16491118","id":"PMC_16491118","title":"Epigenetic inactivation of the Wnt antagonist DICKKOPF-1 (DKK-1) gene in human colorectal cancer.","date":"2006","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/16491118","citation_count":292,"is_preprint":false},{"pmid":"20858621","id":"PMC_20858621","title":"Neutralisation of Dkk-1 protects from systemic bone loss during inflammation and reduces sclerostin expression.","date":"2010","source":"Annals of the rheumatic diseases","url":"https://pubmed.ncbi.nlm.nih.gov/20858621","citation_count":169,"is_preprint":false},{"pmid":"19304568","id":"PMC_19304568","title":"Blockade of Dickkopf (DKK)-1 induces fusion of sacroiliac joints.","date":"2009","source":"Annals of the rheumatic diseases","url":"https://pubmed.ncbi.nlm.nih.gov/19304568","citation_count":167,"is_preprint":false},{"pmid":"10625541","id":"PMC_10625541","title":"Zebrafish Dkk1 functions in forebrain specification and axial mesendoderm formation.","date":"2000","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/10625541","citation_count":159,"is_preprint":false},{"pmid":"15922588","id":"PMC_15922588","title":"SK channels in excitability, pacemaking and synaptic integration.","date":"2005","source":"Current opinion in neurobiology","url":"https://pubmed.ncbi.nlm.nih.gov/15922588","citation_count":148,"is_preprint":false},{"pmid":"27045006","id":"PMC_27045006","title":"Dickkopf-related protein 1 (Dkk1) regulates the accumulation and function of myeloid derived suppressor cells in cancer.","date":"2016","source":"The Journal of experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/27045006","citation_count":140,"is_preprint":false},{"pmid":"26083653","id":"PMC_26083653","title":"Sclerostin and DKK1: new players in renal bone and vascular disease.","date":"2015","source":"Kidney international","url":"https://pubmed.ncbi.nlm.nih.gov/26083653","citation_count":123,"is_preprint":false},{"pmid":"17984176","id":"PMC_17984176","title":"Dickkopf 1 (DKK1) regulates skin pigmentation and thickness by affecting Wnt/beta-catenin signaling in keratinocytes.","date":"2007","source":"FASEB journal : official publication of the Federation of American Societies for Experimental Biology","url":"https://pubmed.ncbi.nlm.nih.gov/17984176","citation_count":122,"is_preprint":false},{"pmid":"22576962","id":"PMC_22576962","title":"Gremlin 1, frizzled-related protein, and Dkk-1 are key regulators of human articular cartilage homeostasis.","date":"2012","source":"Arthritis and rheumatism","url":"https://pubmed.ncbi.nlm.nih.gov/22576962","citation_count":114,"is_preprint":false},{"pmid":"25080367","id":"PMC_25080367","title":"Dkk-1-mediated inhibition of Wnt signaling in bone ameliorates osteoarthritis in mice.","date":"2014","source":"Arthritis & rheumatology (Hoboken, N.J.)","url":"https://pubmed.ncbi.nlm.nih.gov/25080367","citation_count":106,"is_preprint":false},{"pmid":"20957670","id":"PMC_20957670","title":"Dickkopf-1 (DKK-1) stimulated prostate cancer growth and metastasis and inhibited bone formation in osteoblastic bone metastases.","date":"2010","source":"The Prostate","url":"https://pubmed.ncbi.nlm.nih.gov/20957670","citation_count":106,"is_preprint":false},{"pmid":"17515399","id":"PMC_17515399","title":"Dickkopf-1 (DKK1) is a widely expressed and potent tumor-associated antigen in multiple myeloma.","date":"2007","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/17515399","citation_count":101,"is_preprint":false},{"pmid":"22488261","id":"PMC_22488261","title":"Dkk-1 expression in chondrocytes inhibits experimental osteoarthritic cartilage destruction in mice.","date":"2012","source":"Arthritis and rheumatism","url":"https://pubmed.ncbi.nlm.nih.gov/22488261","citation_count":99,"is_preprint":false},{"pmid":"20131282","id":"PMC_20131282","title":"Control of Dkk-1 ameliorates chondrocyte apoptosis, cartilage destruction, and subchondral bone deterioration in osteoarthritic knees.","date":"2010","source":"Arthritis and rheumatism","url":"https://pubmed.ncbi.nlm.nih.gov/20131282","citation_count":83,"is_preprint":false},{"pmid":"19655101","id":"PMC_19655101","title":"Functions and modulation of neuronal SK channels.","date":"2009","source":"Cell biochemistry and biophysics","url":"https://pubmed.ncbi.nlm.nih.gov/19655101","citation_count":69,"is_preprint":false},{"pmid":"24286177","id":"PMC_24286177","title":"GREM1, FRZB and DKK1 mRNA levels correlate with osteoarthritis and are regulated by osteoarthritis-associated factors.","date":"2013","source":"Arthritis research & therapy","url":"https://pubmed.ncbi.nlm.nih.gov/24286177","citation_count":69,"is_preprint":false},{"pmid":"28628652","id":"PMC_28628652","title":"MicroRNA-433-3p promotes osteoblast differentiation through targeting DKK1 expression.","date":"2017","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/28628652","citation_count":66,"is_preprint":false},{"pmid":"29875318","id":"PMC_29875318","title":"Sclerostin neutralization unleashes the osteoanabolic effects of Dkk1 inhibition.","date":"2018","source":"JCI insight","url":"https://pubmed.ncbi.nlm.nih.gov/29875318","citation_count":66,"is_preprint":false},{"pmid":"35355709","id":"PMC_35355709","title":"Drug Discovery of DKK1 Inhibitors.","date":"2022","source":"Frontiers in pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/35355709","citation_count":64,"is_preprint":false},{"pmid":"25351982","id":"PMC_25351982","title":"CBX7 inhibits breast tumorigenicity through DKK-1-mediated suppression of the Wnt/β-catenin pathway.","date":"2014","source":"FASEB journal : official publication of the Federation of American Societies for Experimental Biology","url":"https://pubmed.ncbi.nlm.nih.gov/25351982","citation_count":63,"is_preprint":false},{"pmid":"33536782","id":"PMC_33536782","title":"Expression and Role of Dickkopf-1 (Dkk1) in Tumors: From the Cells to the Patients.","date":"2021","source":"Cancer management and research","url":"https://pubmed.ncbi.nlm.nih.gov/33536782","citation_count":60,"is_preprint":false},{"pmid":"25941031","id":"PMC_25941031","title":"Tumor necrosis factor and interleukin-6 differentially regulate Dkk-1 in the inflamed arthritic joint.","date":"2015","source":"Arthritis & rheumatology (Hoboken, N.J.)","url":"https://pubmed.ncbi.nlm.nih.gov/25941031","citation_count":60,"is_preprint":false},{"pmid":"17154184","id":"PMC_17154184","title":"SK-NEP-1 and Rh1 are Ewing family tumor lines.","date":"2008","source":"Pediatric blood & cancer","url":"https://pubmed.ncbi.nlm.nih.gov/17154184","citation_count":58,"is_preprint":false},{"pmid":"23430197","id":"PMC_23430197","title":"Sclerostin and DKK1 in primary hyperparathyroidism.","date":"2013","source":"Calcified tissue international","url":"https://pubmed.ncbi.nlm.nih.gov/23430197","citation_count":55,"is_preprint":false},{"pmid":"35659360","id":"PMC_35659360","title":"Human amniotic mesenchymal stem cells-derived IGFBP-3, DKK-3, and DKK-1 attenuate liver fibrosis through inhibiting hepatic stellate cell activation by blocking Wnt/β-catenin signaling pathway in mice.","date":"2022","source":"Stem cell research & therapy","url":"https://pubmed.ncbi.nlm.nih.gov/35659360","citation_count":54,"is_preprint":false},{"pmid":"23148317","id":"PMC_23148317","title":"Functional expression of SK channels in murine detrusor PDGFR+ cells.","date":"2012","source":"The Journal of physiology","url":"https://pubmed.ncbi.nlm.nih.gov/23148317","citation_count":54,"is_preprint":false},{"pmid":"32192732","id":"PMC_32192732","title":"Wnt signaling modulator DKK1 as an immunotherapeutic target in ovarian cancer.","date":"2020","source":"Gynecologic oncology","url":"https://pubmed.ncbi.nlm.nih.gov/32192732","citation_count":53,"is_preprint":false},{"pmid":"19675559","id":"PMC_19675559","title":"Regulation of skin pigmentation and thickness by Dickkopf 1 (DKK1).","date":"2009","source":"The journal of investigative dermatology. Symposium proceedings","url":"https://pubmed.ncbi.nlm.nih.gov/19675559","citation_count":51,"is_preprint":false},{"pmid":"21787290","id":"PMC_21787290","title":"The role of BMPs in bone anabolism and their potential targets SOST and DKK1.","date":"2012","source":"Current molecular pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/21787290","citation_count":51,"is_preprint":false},{"pmid":"30291470","id":"PMC_30291470","title":"Dickkopf-1 (Dkk-1) serum levels in systemic sclerosis and rheumatoid arthritis patients: correlation with the Trabecular Bone Score (TBS).","date":"2018","source":"Clinical rheumatology","url":"https://pubmed.ncbi.nlm.nih.gov/30291470","citation_count":49,"is_preprint":false},{"pmid":"30452897","id":"PMC_30452897","title":"Dkk1 involvement and its potential as a biomarker in pancreatic ductal adenocarcinoma.","date":"2018","source":"Clinica chimica acta; international journal of clinical chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/30452897","citation_count":48,"is_preprint":false},{"pmid":"23457386","id":"PMC_23457386","title":"RANKL/OPG ratio and DKK-1 expression in primary osteoblastic cultures from osteoarthritic and osteoporotic subjects.","date":"2013","source":"The Journal of rheumatology","url":"https://pubmed.ncbi.nlm.nih.gov/23457386","citation_count":45,"is_preprint":false},{"pmid":"23266194","id":"PMC_23266194","title":"Dickkopf-1 (DKK1) promotes invasion and metastasis of hepatocellular carcinoma.","date":"2012","source":"Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver","url":"https://pubmed.ncbi.nlm.nih.gov/23266194","citation_count":44,"is_preprint":false},{"pmid":"10559490","id":"PMC_10559490","title":"Expression pattern of Dkk-1 during mouse limb development.","date":"1999","source":"Mechanisms of development","url":"https://pubmed.ncbi.nlm.nih.gov/10559490","citation_count":42,"is_preprint":false},{"pmid":"22736200","id":"PMC_22736200","title":"Dkk-1 promotes angiogenic responses and cartilage matrix proteinase secretion in synovial fibroblasts from osteoarthritic joints.","date":"2012","source":"Arthritis and rheumatism","url":"https://pubmed.ncbi.nlm.nih.gov/22736200","citation_count":42,"is_preprint":false},{"pmid":"24091497","id":"PMC_24091497","title":"Distinct roles of DKK1 and DKK2 in tumor angiogenesis.","date":"2013","source":"Angiogenesis","url":"https://pubmed.ncbi.nlm.nih.gov/24091497","citation_count":41,"is_preprint":false},{"pmid":"28634697","id":"PMC_28634697","title":"In psoriatic arthritis Dkk-1 and PTH are lower than in rheumatoid arthritis and healthy controls.","date":"2017","source":"Clinical rheumatology","url":"https://pubmed.ncbi.nlm.nih.gov/28634697","citation_count":40,"is_preprint":false},{"pmid":"31568519","id":"PMC_31568519","title":"DKK1 promotes hepatocellular carcinoma inflammation, migration and invasion: Implication of TGF-β1.","date":"2019","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/31568519","citation_count":39,"is_preprint":false},{"pmid":"33172955","id":"PMC_33172955","title":"EGF promotes DKK1 transcription in hepatocellular carcinoma by enhancing the phosphorylation and acetylation of histone H3.","date":"2020","source":"Science signaling","url":"https://pubmed.ncbi.nlm.nih.gov/33172955","citation_count":38,"is_preprint":false},{"pmid":"25942650","id":"PMC_25942650","title":"SK channels and calmodulin.","date":"2015","source":"Channels (Austin, Tex.)","url":"https://pubmed.ncbi.nlm.nih.gov/25942650","citation_count":37,"is_preprint":false},{"pmid":"34831180","id":"PMC_34831180","title":"Perspectives on miRNAs Targeting DKK1 for Developing Hair Regeneration Therapy.","date":"2021","source":"Cells","url":"https://pubmed.ncbi.nlm.nih.gov/34831180","citation_count":37,"is_preprint":false},{"pmid":"31208278","id":"PMC_31208278","title":"LncRNA XIST facilitates cell growth, migration and invasion via modulating H3 histone methylation of DKK1 in neuroblastoma.","date":"2019","source":"Cell cycle (Georgetown, Tex.)","url":"https://pubmed.ncbi.nlm.nih.gov/31208278","citation_count":37,"is_preprint":false},{"pmid":"20439124","id":"PMC_20439124","title":"Dkk1 and Dkk2 regulate epicardial specification during mouse heart development.","date":"2010","source":"International journal of cardiology","url":"https://pubmed.ncbi.nlm.nih.gov/20439124","citation_count":37,"is_preprint":false},{"pmid":"36165920","id":"PMC_36165920","title":"New Emerging Biomarkers for Bone Disease: Sclerostin and Dickkopf-1 (DKK1).","date":"2022","source":"Calcified tissue international","url":"https://pubmed.ncbi.nlm.nih.gov/36165920","citation_count":35,"is_preprint":false},{"pmid":"19820386","id":"PMC_19820386","title":"Clinical significance of serum DKK-1 in patients with gynecological cancer.","date":"2009","source":"International journal of gynecological cancer : official journal of the International Gynecological Cancer Society","url":"https://pubmed.ncbi.nlm.nih.gov/19820386","citation_count":35,"is_preprint":false},{"pmid":"30910600","id":"PMC_30910600","title":"Changes in Dkk-1, sclerostin, and RANKL serum levels following discontinuation of long-term denosumab treatment in postmenopausal women.","date":"2019","source":"Bone","url":"https://pubmed.ncbi.nlm.nih.gov/30910600","citation_count":34,"is_preprint":false},{"pmid":"30420710","id":"PMC_30420710","title":"Identification of DKK-1 as a novel mediator of statin effects in human endothelial cells.","date":"2018","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/30420710","citation_count":33,"is_preprint":false},{"pmid":"28229932","id":"PMC_28229932","title":"CSN5/JAB1 suppresses the WNT inhibitor DKK1 in colorectal cancer cells.","date":"2017","source":"Cellular signalling","url":"https://pubmed.ncbi.nlm.nih.gov/28229932","citation_count":33,"is_preprint":false},{"pmid":"25344678","id":"PMC_25344678","title":"Preliminary mechanism on the methylation modification of Dkk-1 and Dkk-3 in hepatocellular carcinoma.","date":"2014","source":"Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine","url":"https://pubmed.ncbi.nlm.nih.gov/25344678","citation_count":31,"is_preprint":false},{"pmid":"19776352","id":"PMC_19776352","title":"Dkk-1 inhibits intestinal epithelial cell migration by attenuating directional polarization of leading edge cells.","date":"2009","source":"Molecular biology of the cell","url":"https://pubmed.ncbi.nlm.nih.gov/19776352","citation_count":31,"is_preprint":false},{"pmid":"30906632","id":"PMC_30906632","title":"Dickkopf-1 (DKK1) promotes tumor growth via Akt-phosphorylation and independently of Wnt-axis in Barrett's associated esophageal adenocarcinoma.","date":"2019","source":"American journal of cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/30906632","citation_count":30,"is_preprint":false},{"pmid":"20144607","id":"PMC_20144607","title":"The regulation of Dkk1 expression during embryonic development.","date":"2010","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/20144607","citation_count":30,"is_preprint":false},{"pmid":"29772510","id":"PMC_29772510","title":"DKK1 and Kremen Expression Predicts the Osteoblastic Response to Bone Metastasis.","date":"2018","source":"Translational oncology","url":"https://pubmed.ncbi.nlm.nih.gov/29772510","citation_count":29,"is_preprint":false},{"pmid":"25111416","id":"PMC_25111416","title":"Sclerostin and Dkk-1 in patients with ankylosing spondylitis.","date":"2014","source":"Acta reumatologica portuguesa","url":"https://pubmed.ncbi.nlm.nih.gov/25111416","citation_count":29,"is_preprint":false},{"pmid":"15942669","id":"PMC_15942669","title":"Comparative genomics on Dkk1 orthologs.","date":"2005","source":"International journal of oncology","url":"https://pubmed.ncbi.nlm.nih.gov/15942669","citation_count":29,"is_preprint":false},{"pmid":"25231759","id":"PMC_25231759","title":"Head formation: OTX2 regulates Dkk1 and Lhx1 activity in the anterior mesendoderm.","date":"2014","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/25231759","citation_count":29,"is_preprint":false},{"pmid":"32329150","id":"PMC_32329150","title":"SOX9-activated PXN-AS1 promotes the tumorigenesis of glioblastoma by EZH2-mediated methylation of DKK1.","date":"2020","source":"Journal of cellular and molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/32329150","citation_count":29,"is_preprint":false},{"pmid":"32185280","id":"PMC_32185280","title":"Dkk1: A key molecule in joint remodelling and fibrosis.","date":"2017","source":"Mediterranean journal of rheumatology","url":"https://pubmed.ncbi.nlm.nih.gov/32185280","citation_count":28,"is_preprint":false},{"pmid":"22210558","id":"PMC_22210558","title":"Potential role for therapies targeting DKK1, LRP5, and serotonin in the treatment of osteoporosis.","date":"2012","source":"Current osteoporosis reports","url":"https://pubmed.ncbi.nlm.nih.gov/22210558","citation_count":28,"is_preprint":false},{"pmid":"31921182","id":"PMC_31921182","title":"Loss of Dkk-1 in Osteocytes Mitigates Alveolar Bone Loss in Mice With Periodontitis.","date":"2019","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/31921182","citation_count":28,"is_preprint":false},{"pmid":"23636253","id":"PMC_23636253","title":"Dickkopf-1 (DKK1) phosphatase and tensin homolog on chromosome 10 (PTEN) crosstalk via microRNA interference in the diabetic heart.","date":"2013","source":"Basic research in cardiology","url":"https://pubmed.ncbi.nlm.nih.gov/23636253","citation_count":28,"is_preprint":false},{"pmid":"26960688","id":"PMC_26960688","title":"miR-522 contributes to cell proliferation of hepatocellular carcinoma by targeting DKK1 and SFRP2.","date":"2016","source":"Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine","url":"https://pubmed.ncbi.nlm.nih.gov/26960688","citation_count":28,"is_preprint":false},{"pmid":"30746507","id":"PMC_30746507","title":"Wnt Pathway Inhibitor DKK1: A Potential Novel Biomarker for Adiposity.","date":"2019","source":"Journal of the Endocrine Society","url":"https://pubmed.ncbi.nlm.nih.gov/30746507","citation_count":27,"is_preprint":false},{"pmid":"17339226","id":"PMC_17339226","title":"Neurospora spore killers Sk-2 and Sk-3 suppress meiotic silencing by unpaired DNA.","date":"2007","source":"Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/17339226","citation_count":27,"is_preprint":false},{"pmid":"24479159","id":"PMC_24479159","title":"Dkk1 in the peri-cloaca mesenchyme regulates formation of anorectal and genitourinary tracts.","date":"2014","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/24479159","citation_count":27,"is_preprint":false},{"pmid":"28682874","id":"PMC_28682874","title":"In vitro effect of microRNA-107 targeting Dkk-1 by regulation of Wnt/β-catenin signaling pathway in osteosarcoma.","date":"2017","source":"Medicine","url":"https://pubmed.ncbi.nlm.nih.gov/28682874","citation_count":27,"is_preprint":false},{"pmid":"31968132","id":"PMC_31968132","title":"Biomarkers in WNT1 and PLS3 Osteoporosis: Altered Concentrations of DKK1 and FGF23.","date":"2020","source":"Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research","url":"https://pubmed.ncbi.nlm.nih.gov/31968132","citation_count":26,"is_preprint":false},{"pmid":"29956067","id":"PMC_29956067","title":"IL-1β Enhances Wnt Signal by Inhibiting DKK1.","date":"2018","source":"Inflammation","url":"https://pubmed.ncbi.nlm.nih.gov/29956067","citation_count":26,"is_preprint":false},{"pmid":"36812308","id":"PMC_36812308","title":"Asprosin promotes feeding through SK channel-dependent activation of AgRP neurons.","date":"2023","source":"Science advances","url":"https://pubmed.ncbi.nlm.nih.gov/36812308","citation_count":25,"is_preprint":false},{"pmid":"22038356","id":"PMC_22038356","title":"Specific inhibitory protein Dkk-1 blocking Wnt/β-catenin signaling pathway improve protectives effect on the extracellular matrix.","date":"2011","source":"Journal of Huazhong University of Science and Technology. Medical sciences = Hua zhong ke ji da xue xue bao. Yi xue Ying De wen ban = Huazhong keji daxue xuebao. Yixue Yingdewen ban","url":"https://pubmed.ncbi.nlm.nih.gov/22038356","citation_count":25,"is_preprint":false},{"pmid":"36506070","id":"PMC_36506070","title":"Wnt signaling pathway inhibitors, sclerostin and DKK-1, correlate with pain and bone pathology in patients with Gaucher disease.","date":"2022","source":"Frontiers in endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/36506070","citation_count":24,"is_preprint":false},{"pmid":"36001113","id":"PMC_36001113","title":"TGF-β1/Smad3 upregulates UCA1 to promote liver fibrosis through DKK1 and miR18a.","date":"2022","source":"Journal of molecular medicine (Berlin, Germany)","url":"https://pubmed.ncbi.nlm.nih.gov/36001113","citation_count":24,"is_preprint":false},{"pmid":"26414930","id":"PMC_26414930","title":"Expression of Wnt3a, Wnt10b, β-catenin and DKK1 in periodontium during orthodontic tooth movement in rats.","date":"2015","source":"Acta odontologica Scandinavica","url":"https://pubmed.ncbi.nlm.nih.gov/26414930","citation_count":23,"is_preprint":false},{"pmid":"25436422","id":"PMC_25436422","title":"Induction of DKK1 by ox-LDL negatively regulates intracellular lipid accumulation in macrophages.","date":"2014","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/25436422","citation_count":23,"is_preprint":false},{"pmid":"32592422","id":"PMC_32592422","title":"Wnt antagonist DKK-1 levels in systemic sclerosis are lower in skin but not in blood and are regulated by microRNA33a-3p.","date":"2020","source":"Experimental dermatology","url":"https://pubmed.ncbi.nlm.nih.gov/32592422","citation_count":23,"is_preprint":false},{"pmid":"24681007","id":"PMC_24681007","title":"Expanding role of SK channels in cardiac electrophysiology.","date":"2014","source":"Heart rhythm","url":"https://pubmed.ncbi.nlm.nih.gov/24681007","citation_count":22,"is_preprint":false},{"pmid":"33420361","id":"PMC_33420361","title":"Hypoxia-induced CREB cooperates MMSET to modify chromatin and promote DKK1 expression in multiple myeloma.","date":"2021","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/33420361","citation_count":22,"is_preprint":false},{"pmid":"31538414","id":"PMC_31538414","title":"miR-29a promotes osteoblast proliferation by downregulating DKK-1 expression and activating Wnt/β-catenin signaling pathway.","date":"2019","source":"Advances in clinical and experimental medicine : official organ Wroclaw Medical University","url":"https://pubmed.ncbi.nlm.nih.gov/31538414","citation_count":22,"is_preprint":false},{"pmid":"29084466","id":"PMC_29084466","title":"Elevated Expression of Dkk-1 by Glucocorticoid Treatment Impairs Bone Regenerative Capacity of Adipose Tissue-Derived Mesenchymal Stem Cells.","date":"2018","source":"Stem cells and development","url":"https://pubmed.ncbi.nlm.nih.gov/29084466","citation_count":22,"is_preprint":false},{"pmid":"31963554","id":"PMC_31963554","title":"DKK1 Induced by 1,25D3 Is Required for the Mineralization of Osteoblasts.","date":"2020","source":"Cells","url":"https://pubmed.ncbi.nlm.nih.gov/31963554","citation_count":21,"is_preprint":false},{"pmid":"33066846","id":"PMC_33066846","title":"Artesunate promotes osteoblast differentiation through miR-34a/DKK1 axis.","date":"2020","source":"Acta histochemica","url":"https://pubmed.ncbi.nlm.nih.gov/33066846","citation_count":20,"is_preprint":false},{"pmid":"32828314","id":"PMC_32828314","title":"LncRNA Linc-PINT inhibits miR-523-3p to hamper retinoblastoma progression by upregulating Dickkopf-1 (DKK1).","date":"2020","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/32828314","citation_count":20,"is_preprint":false},{"pmid":"35924447","id":"PMC_35924447","title":"DKK1 drives immune suppressive phenotypes in intrahepatic cholangiocarcinoma and can be targeted with anti-DKK1 therapeutic DKN-01.","date":"2022","source":"Liver international : official journal of the International Association for the Study of the Liver","url":"https://pubmed.ncbi.nlm.nih.gov/35924447","citation_count":19,"is_preprint":false},{"pmid":"34697293","id":"PMC_34697293","title":"ZBTB38 suppresses prostate cancer cell proliferation and migration via directly promoting DKK1 expression.","date":"2021","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/34697293","citation_count":19,"is_preprint":false},{"pmid":"20846389","id":"PMC_20846389","title":"Differential expression of DKK-1 binding receptors on stromal cells and myeloma cells results in their distinct response to secreted DKK-1 in myeloma.","date":"2010","source":"Molecular cancer","url":"https://pubmed.ncbi.nlm.nih.gov/20846389","citation_count":19,"is_preprint":false},{"pmid":"22459449","id":"PMC_22459449","title":"Characterization of Dkk1 gene regulation by the osteoblast-specific transcription factor Osx.","date":"2012","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/22459449","citation_count":19,"is_preprint":false},{"pmid":"38067123","id":"PMC_38067123","title":"Effects of Dickkopf-1 (DKK-1) on Prostate Cancer Growth and Bone Metastasis.","date":"2023","source":"Cells","url":"https://pubmed.ncbi.nlm.nih.gov/38067123","citation_count":18,"is_preprint":false},{"pmid":"16195809","id":"PMC_16195809","title":"Dkk1, -2, and -3 expression in mouse craniofacial development.","date":"2005","source":"Journal of molecular histology","url":"https://pubmed.ncbi.nlm.nih.gov/16195809","citation_count":18,"is_preprint":false},{"pmid":"35743102","id":"PMC_35743102","title":"DKK-1 Is Underexpressed in Mesenchymal Stem Cells from Patients with Ankylosing Spondylitis and Further Downregulated by IL-17.","date":"2022","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/35743102","citation_count":18,"is_preprint":false},{"pmid":"28151034","id":"PMC_28151034","title":"sFRP3 and DKK1 Regulate Fibroblast-Like Synoviocytes Markers and Wnt Elements Expression Depending on Cellular Context.","date":"2017","source":"Immunological investigations","url":"https://pubmed.ncbi.nlm.nih.gov/28151034","citation_count":18,"is_preprint":false},{"pmid":"23251700","id":"PMC_23251700","title":"High-affinity Dkk1 receptor Kremen1 is internalized by clathrin-mediated endocytosis.","date":"2012","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/23251700","citation_count":17,"is_preprint":false},{"pmid":"26880631","id":"PMC_26880631","title":"Dkk1: A promising molecule to connect Alzheimer's disease and osteoporosis.","date":"2016","source":"Medical hypotheses","url":"https://pubmed.ncbi.nlm.nih.gov/26880631","citation_count":17,"is_preprint":false},{"pmid":"36718957","id":"PMC_36718957","title":"DKK1-CKAP4 signal axis promotes hepatocellular carcinoma aggressiveness.","date":"2023","source":"Cancer science","url":"https://pubmed.ncbi.nlm.nih.gov/36718957","citation_count":16,"is_preprint":false},{"pmid":"37039367","id":"PMC_37039367","title":"Inflammation and DKK1-induced AKT activation contribute to endothelial dysfunction following NR2F2 loss.","date":"2023","source":"American journal of physiology. Lung cellular and molecular physiology","url":"https://pubmed.ncbi.nlm.nih.gov/37039367","citation_count":16,"is_preprint":false},{"pmid":"28993177","id":"PMC_28993177","title":"DKK1 and sclerostin are early markers of relapse in multiple myeloma.","date":"2017","source":"Bone","url":"https://pubmed.ncbi.nlm.nih.gov/28993177","citation_count":16,"is_preprint":false},{"pmid":"34546340","id":"PMC_34546340","title":"DKK1 suppresses WWP2 to enhance bortezomib resistance in multiple myeloma via regulating GLI2 ubiquitination.","date":"2021","source":"Carcinogenesis","url":"https://pubmed.ncbi.nlm.nih.gov/34546340","citation_count":15,"is_preprint":false},{"pmid":"22430125","id":"PMC_22430125","title":"Dickkopf-1 (DKK-1) interrupts FAK/PI3K/mTOR pathway by interaction of carbonic anhydrase IX (CA9) in tumorigenesis.","date":"2012","source":"Cellular signalling","url":"https://pubmed.ncbi.nlm.nih.gov/22430125","citation_count":15,"is_preprint":false},{"pmid":"34703266","id":"PMC_34703266","title":"Niacinamide Down-Regulates the Expression of DKK-1 and Protects Cells from Oxidative Stress in Cultured Human Dermal Papilla Cells.","date":"2021","source":"Clinical, cosmetic and investigational dermatology","url":"https://pubmed.ncbi.nlm.nih.gov/34703266","citation_count":15,"is_preprint":false},{"pmid":"38961399","id":"PMC_38961399","title":"DKK1 loss promotes endometrial fibrosis via autophagy and exosome-mediated macrophage-to-myofibroblast transition.","date":"2024","source":"Journal of translational medicine","url":"https://pubmed.ncbi.nlm.nih.gov/38961399","citation_count":14,"is_preprint":false},{"pmid":"33422768","id":"PMC_33422768","title":"Differential modulation of SK channel subtypes by phosphorylation.","date":"2021","source":"Cell calcium","url":"https://pubmed.ncbi.nlm.nih.gov/33422768","citation_count":14,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":56372,"output_tokens":10132,"usd":0.160548,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":20430,"output_tokens":5160,"usd":0.115575,"stage2_stop_reason":"end_turn"},"total_usd":0.276123,"stage1_batch_id":"msgbatch_01AsR7g8dGTEiEw9U83bJeWn","stage2_batch_id":"msgbatch_01YV5ZyxtFNUZEjxRcpd9jzb","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1999,\n      \"finding\": \"DKK1 is expressed in the Spemann organizer/prechordal plate and functions as a secreted Wnt antagonist; ectopic expression in zebrafish enlarged forebrain, eyes, and axial mesendoderm, and rescued forebrain/notochord defects in bozozok mutants, establishing that Dkk1 acts in dorsal mesendoderm to pattern the anterior nervous system and axial mesendoderm independently of dorso-anterior mesendoderm.\",\n      \"method\": \"Ectopic expression (mRNA injection), genetic epistasis in zebrafish mutants (boz, sqt, oep), in situ hybridization\",\n      \"journal\": \"Developmental biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — epistasis across multiple zebrafish mutants, gain-of-function rescue, replicated across multiple genetic backgrounds in one rigorous study\",\n      \"pmids\": [\"10625541\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"Dkk-1 is expressed in interdigital mesenchyme during mouse limb development (E9.0–E14.5), with posterior expression initially overlapping Shh, suggesting a role in digit patterning downstream of key limb signaling molecules.\",\n      \"method\": \"Whole-mount in situ hybridization, double whole-mount in situ hybridization with Shh\",\n      \"journal\": \"Mechanisms of development\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — detailed expression mapping with spatial co-localization of Dkk1 and Shh, single lab, no loss-of-function\",\n      \"pmids\": [\"10559490\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"DKK-1 gene is transcriptionally silenced by CpG island promoter hypermethylation in colon cancer cell lines; treatment with 5-aza-2'-deoxycytidine restored expression. Restoration of DKK-1 in non-expressing cells with truncated APC had no effect on β-catenin/TCF-dependent transcription but induced tumor suppressor-like features (reduced colony formation, tumor growth inhibition in nude mice), indicating DKK-1 functions independently of canonical Wnt signaling in this context.\",\n      \"method\": \"Bisulfite sequencing/methylation-specific PCR, 5-aza-2'-deoxycytidine demethylation, colony formation assay, nude mouse xenograft, luciferase TCF reporter assay\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple orthogonal methods (epigenetic, functional in vitro and in vivo) in a single rigorous study\",\n      \"pmids\": [\"16491118\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"DKK1 secreted by dermal fibroblasts suppresses melanocyte function and growth by downregulating MITF and β-catenin, and increases keratinocyte proliferation while decreasing melanin uptake; treatment of reconstructed skin with DKK1 induced a thicker, less pigmented epidermis, reproducing the palmoplantar phenotype through Wnt/β-catenin pathway modulation.\",\n      \"method\": \"Recombinant DKK1 treatment of keratinocytes and reconstructed skin, DNA microarray, RT-PCR, Western blotting\",\n      \"journal\": \"FASEB journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple orthogonal methods (transcriptomics, protein validation, 3D skin model), mechanistically linked to Wnt/β-catenin and MITF regulation\",\n      \"pmids\": [\"17984176\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Dkk-1 inhibits intestinal epithelial cell migration by inducing mislocalized activation of Cdc42, displacing the polarity protein Par6 from the leading edge, and persistently inhibiting relocation of the microtubule organizing center and Golgi apparatus in the direction of migration; siRNA knockdown of Dkk-1 confirmed that extracellular Dkk-1 was required for this polarity defect.\",\n      \"method\": \"Wound healing assay, recombinant Dkk-1 treatment, siRNA knockdown, immunofluorescence of Cdc42, Par6, MTOC, and Golgi\",\n      \"journal\": \"Molecular biology of the cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — reciprocal gain/loss-of-function with specific molecular readouts (Cdc42 localization, Par6, MTOC, Golgi) in a single rigorous study\",\n      \"pmids\": [\"19776352\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"Neutralization of Dkk-1 in TNF-transgenic mice completely protected from inflammatory bone loss by preventing TNF-mediated impairment of osteoblast function and enhanced osteoclast activity; TNF rapidly increased Dkk-1 expression in primary osteoblasts in vitro, blocking osteoblast differentiation; Dkk-1 blockade also reduced sclerostin expression in differentiated osteoblasts in vitro and in vivo, and reduced osteocyte death.\",\n      \"method\": \"Anti-Dkk-1 neutralizing antibody in hTNFtg mice, bone histomorphometry, β-catenin/osteocalcin/OPG immunohistochemistry, in vitro primary osteoblast stimulation with TNF\",\n      \"journal\": \"Annals of the rheumatic diseases\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — in vivo neutralization combined with in vitro mechanistic follow-up, multiple orthogonal readouts\",\n      \"pmids\": [\"20858621\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"Blockade of DKK1 in TNF-transgenic mice reduced bone erosions and osteoclast counts, promoted hypertrophic chondrocyte formation (collagen type X expression), and induced ankylosis of sacroiliac joints, without affecting inflammation; this demonstrates DKK1 normally suppresses Wnt-driven new bone formation in inflammatory joint disease.\",\n      \"method\": \"Anti-DKK1 antibody treatment in TNFtg mice, histology, immunohistochemistry for collagen X, β-catenin, osteoclast counting\",\n      \"journal\": \"Annals of the rheumatic diseases\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — in vivo antibody blockade with multiple histological and molecular readouts\",\n      \"pmids\": [\"19304568\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"DKK-1 overexpression in Ace-1 prostate cancer cells increased subcutaneous tumor mass and incidence of bone metastases associated with increased phospho-JNK (non-canonical Wnt pathway), while decreasing the osteoblastic phenotype of bone metastases by inhibiting TCF activity in osteoblast precursors (canonical Wnt pathway).\",\n      \"method\": \"Stable DKK-1 overexpression, intracardiac/intratibial injection in athymic mice, bioluminescent imaging, micro-CT, histopathology, TCF luciferase assay in ST2 cells, Western blot for phospho-JNK\",\n      \"journal\": \"The Prostate\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — in vivo and in vitro with multiple orthogonal mechanistic readouts including pathway-specific reporter and kinase phosphorylation\",\n      \"pmids\": [\"20957670\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"Dkk-1 and Dkk-2 redundantly inhibit Wnt signaling to regulate myocardial proliferation during mouse heart development; double null embryos show myocardial hypertrophy with increased cell proliferation and epicardial hypercellularity with broadened Connexin 43 expression from proepicardial precursors.\",\n      \"method\": \"Double Dkk1/Dkk2 null mouse genetics, histology, immunohistochemistry, BrdU proliferation assay\",\n      \"journal\": \"International journal of cardiology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic double-null epistasis in mouse, single lab, defined cellular phenotype\",\n      \"pmids\": [\"20439124\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"DKK1 overexpression in chondrocytes (Col2a1-Dkk1 transgenic mice or intraarticular AdDkk-1 injection) inhibited DMM-induced experimental osteoarthritis; Wnt-3a-induced expression of Mmp13 and Adamts4 in chondrocytes was blocked by Dkk-1 pretreatment, establishing that Dkk-1 protects cartilage by suppressing Wnt-mediated catabolic factor expression.\",\n      \"method\": \"Chondrocyte-specific transgenic mice, intraarticular adenoviral injection, OA scoring, recombinant Wnt-3a/Dkk-1 treatment of primary chondrocytes, RT-PCR for Mmp13/Adamts4\",\n      \"journal\": \"Arthritis and rheumatism\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — in vivo transgenic and adenoviral gain-of-function with in vitro pathway validation, multiple orthogonal methods\",\n      \"pmids\": [\"22488261\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"Dkk-1 in synovial fibroblasts upregulates HIF-1α and angiogenic factors (SDF-1, CSF-1) and proteinases (ADAMTS-5, MMP-3) through stabilization of GSK3β-Ser9, β-catenin, TCF4, and ERK signaling; IL-1β-induced Dkk-1 promotes angiogenesis in endothelial cells. Knockdown of HIF-1α decreased Dkk-1–driven angiogenic factor expression.\",\n      \"method\": \"Anti-Dkk-1 antibody, siRNA knockdown, IL-1β stimulation, HIF-1α siRNA, ELISA, RT-PCR, in vitro angiogenesis assay, in vivo Dkk-1 antisense oligonucleotide in rat OA\",\n      \"journal\": \"Arthritis and rheumatism\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple orthogonal methods (antibody neutralization, siRNA, in vivo) with defined molecular pathway\",\n      \"pmids\": [\"22736200\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"Osteoblast-specific transcription factor Osterix (Osx) directly binds to two GC-rich sites in the proximal 250 bp of the Dkk1 promoter and activates Dkk1 transcription; Dkk1 expression was downregulated in Osx-null calvaria and after Osx siRNA knockdown, and upregulated upon Osx overexpression.\",\n      \"method\": \"ChIP-qPCR, promoter deletion luciferase assays, siRNA knockdown, Osx overexpression in Tet-off C2C12 cells, Osx-null embryo calvaria RT-PCR\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — ChIP combined with promoter deletion mutagenesis and genetic loss-of-function, multiple orthogonal methods\",\n      \"pmids\": [\"22459449\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"Kremens (high-affinity DKK1 receptors) internalize DKK1 from the cell surface via clathrin-mediated endocytosis; Kremen1 contains an atypical dileucine motif (DXXXLV) required for internalization, and mutation of LV to AA blocked internalization; AP-2 inhibition or pitstop 2 (clathrin inhibitor) also blocked Kremen1 internalization.\",\n      \"method\": \"Mutagenesis of Kremen1 dileucine motif, AP-2 siRNA knockdown, clathrin inhibitor pitstop 2, flow cytometry/cell surface assay\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — site-directed mutagenesis combined with pharmacological and genetic inhibition, single lab\",\n      \"pmids\": [\"23251700\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"DKK1 inhibits tumor angiogenesis and reduces pericyte coverage of tumor blood vessels in B16F10 melanoma-bearing mice, while DKK2 has opposite pro-angiogenic effects; these differential roles were confirmed in endothelial-specific DKK1/DKK2 transgenic mice and in an oxygen-induced retinopathy model.\",\n      \"method\": \"Adenoviral DKK1/DKK2 expression in tumor-bearing mice, endothelial-specific transgenic mice, tumor vascular density/perfusion quantification, pericyte coverage, oxygen-induced retinopathy model\",\n      \"journal\": \"Angiogenesis\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple in vivo models (tumor, transgenic, retinopathy) with consistent results\",\n      \"pmids\": [\"24091497\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"OTX2 directly activates Dkk1 expression by binding to the H1 regulatory region of Dkk1 in the anterior mesendoderm; tissue-specific ablation of Otx2 in the AME disrupted Dkk1 expression and phenocopied head truncation; compound Otx2;Dkk1 mutants showed enhanced head defects.\",\n      \"method\": \"Conditional Otx2 knockout, ChIP-qPCR, RT-qPCR, luciferase reporter assay, cross-species comparative analysis, genetic epistasis (compound mutants)\",\n      \"journal\": \"Development (Cambridge, England)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — ChIP validation of direct binding, luciferase reporter, genetic epistasis in compound mutants\",\n      \"pmids\": [\"25231759\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"Dkk-1 overexpression in bone (Col1a1-Dkk1 transgenic mice) ameliorated OA severity after meniscectomy by reducing subchondral bone Wnt/β-catenin activation, decreasing VEGF in osteoblasts, and thereby reducing MMP expression in chondrocytes; direct cartilage exposure to Dkk-1 caused proteoglycan loss and increased NITEGE expression, indicating distinct bone-mediated vs. direct cartilage effects.\",\n      \"method\": \"Col1a1-Dkk1 transgenic mice, meniscectomy OA model, X-Gal staining (Topgal reporter), micro-CT, histomorphometry, cartilage explant culture, VEGF/MMP mRNA analysis\",\n      \"journal\": \"Arthritis & rheumatology (Hoboken, N.J.)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — in vivo transgenic with Wnt reporter, multiple downstream pathway measurements, and orthogonal in vitro validation\",\n      \"pmids\": [\"25080367\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"DKK-1 interacts with carbonic anhydrase IX (CA9) via the Val60-Tyr168 site of DKK-1 binding to the N-terminal domain of CA9 in vitro and in vivo; DKK-1 overexpression inhibited CA9-mediated mTOR phosphorylation and endothelial cell angiogenesis in tumorigenesis.\",\n      \"method\": \"Co-immunoprecipitation, domain mapping, mTOR phosphorylation assay, endothelial cell angiogenesis assay\",\n      \"journal\": \"Cellular signalling\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — binding domain mapping by co-IP with functional downstream readout, single lab\",\n      \"pmids\": [\"22430125\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"Dkk1 expression in peri-cloacal mesenchyme regulates anorectal and genitourinary tract formation; conditional Dkk1 deletion causes imperforate anus with rectourinary fistula and preputial hypospadias, associated with ectopic expansion of dorsal peri-cloacal mesenchyme (increased proliferation/survival) and elevated Wnt/β-catenin, Shh, Fgf8, and Bmp4 activity; genetic hyperactivation of Wnt/β-catenin in cloacal mesenchyme partially recapitulates Dkk1 mutant phenotypes.\",\n      \"method\": \"Conditional Dkk1 knockout mouse, β-catenin activation transgenic epistasis, histology, immunohistochemistry, BrdU proliferation assay\",\n      \"journal\": \"Developmental biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — conditional KO with epistasis via Wnt gain-of-function, multiple cellular and molecular phenotypes\",\n      \"pmids\": [\"24479159\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"ox-LDL induces DKK1 expression in macrophages; DKK1 in turn decreases LOX-1 via Wnt/β-catenin pathway and increases ABCA/G1 via STAT3 pathway, thereby inhibiting cholesterol loading in macrophages.\",\n      \"method\": \"ox-LDL stimulation of macrophages, Western blot for LOX-1/ABCA1/ABCG1/β-catenin, STAT3 pathway analysis\",\n      \"journal\": \"FEBS letters\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — in vitro pathway analysis with downstream targets, single lab, no direct DKK1 gain/loss-of-function\",\n      \"pmids\": [\"25436422\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"CBX7 inhibits Wnt/β-catenin/TCF pathway by enhancing DKK-1 transcription through cooperation with p300 acetyltransferase, increasing histone acetylation at the DKK-1 promoter; pharmacologic DKK-1 inhibition in CBX7-overexpressing cells restored Wnt signaling and the CD44+/CD24−/ESA+ stem cell population.\",\n      \"method\": \"ChIP for histone acetylation at DKK-1 promoter, co-IP of CBX7 with p300, luciferase reporter, DKK-1 pharmacological inhibition, flow cytometry for stem cell markers\",\n      \"journal\": \"FASEB journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Moderate — ChIP showing histone acetylation, Co-IP of the CBX7-p300 complex, functional DKK-1 inhibition rescue, single lab\",\n      \"pmids\": [\"25351982\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"TNF strongly induces DKK-1 production in fibroblast-like synoviocytes, whereas IL-6 suppresses DKK-1 production and abrogates TNF-induced DKK-1 upregulation; the inverse correlation between DKK-1 and IL-6 levels in synovial fluid was confirmed in vitro in FLS cultures.\",\n      \"method\": \"FLS cell culture stimulation with TNF/IL-1β/IL-6, ELISA for DKK-1, correlation analysis in synovial fluid samples\",\n      \"journal\": \"Arthritis & rheumatology (Hoboken, N.J.)\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — in vitro cytokine regulation confirmed by in vivo correlation, single lab\",\n      \"pmids\": [\"25941031\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Stroma-derived DKK1 targets β-catenin in MDSCs to suppress their immune function and promote tumor growth; DKK1 neutralization decreases MDSC numbers by rescuing β-catenin; recombinant DKK1 suppressed β-catenin target genes in MDSCs from mice and humans; anti-DKK1 antitumor effects were lost in mice lacking β-catenin in myeloid cells or after MDSC depletion.\",\n      \"method\": \"DKK1 neutralizing antibody in tumor-bearing mice, myeloid-specific β-catenin conditional knockout epistasis, MDSC depletion, recombinant DKK1 treatment, flow cytometry, gene expression analysis\",\n      \"journal\": \"The Journal of experimental medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple orthogonal approaches including conditional KO epistasis, antibody neutralization, and recombinant protein, validated in both mouse and human cells\",\n      \"pmids\": [\"27045006\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"Conditional deletion of Dkk1 from bone has negligible effects on bone mass unless sclerostin (Sost) is also removed; Dkk1 inhibition increases Sost expression as a compensatory mechanism. Combined deletion of Dkk1 and Sost, or co-administration of anti-Dkk1 and anti-sclerostin antibodies, produced synergistic anabolic bone gain exceeding individual or additive effects.\",\n      \"method\": \"Conditional Dkk1 bone-specific knockout, Sost osteocyte-specific knockout epistasis, sclerostin neutralizing antibody, DXA, μCT, histomorphometry, biomechanical testing\",\n      \"journal\": \"JCI insight\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — conditional double KO genetic epistasis validated by antibody co-treatment, multiple bone measurement modalities\",\n      \"pmids\": [\"29875318\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"Atorvastatin downregulates DKK-1 protein and mRNA through inhibition of Cdc42, Rho, and Rac geranylgeranylated proteins; DKK-1 itself mediates ~21% of statin-modulated proteins in endothelial cells, including clusterin/apoJ, PAI-1, MARCKS, and PTX3, establishing DKK-1 as a downstream effector of statin action.\",\n      \"method\": \"Label-free quantitative mass spectrometry proteomics, DKK-1 siRNA gene silencing, mRNA quantification, statin treatment ± geranylgeranyl pathway inhibitors, in vivo rabbit model\",\n      \"journal\": \"Scientific reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — proteomics combined with gene silencing and in vivo validation, multiple orthogonal methods\",\n      \"pmids\": [\"30420710\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"Osteocyte-specific deletion of Dkk-1 prevented alveolar bone loss in experimental periodontitis in mice, increasing bone volume/density, reducing osteoclast numbers, increasing bone formation markers (Runx2, Osteocalcin), decreasing RANKL expression, and reducing local inflammatory infiltrates; serum Dkk-1 was reduced and TCF-7 expression increased in these mice.\",\n      \"method\": \"Dkk-1fl/fl;Dmp1:Cre osteocyte-specific conditional knockout, experimental periodontitis ligature model, micro-CT, histomorphometry, RT-PCR, ELISA for Dkk-1/CTX/P1NP\",\n      \"journal\": \"Frontiers in immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — cell-type-specific conditional knockout in disease model with multiple in vivo molecular and structural readouts\",\n      \"pmids\": [\"31921182\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"DKK1 knockdown in OE33 esophageal adenocarcinoma cells attenuated viability, proliferation, migration, and invasion; these effects were not mediated through the canonical β-catenin pathway but through downstream Akt phosphorylation; Wnt3a restored Akt phosphorylation in DKK1-depleted cells without further stimulating β-catenin transcription, indicating a Wnt-axis-independent oncogenic role for DKK1 via Akt.\",\n      \"method\": \"siRNA DKK1 knockdown, recombinant DKK1/Wnt3a treatment, Akt phosphorylation Western blot, β-catenin reporter assay, proliferation/migration/invasion assays\",\n      \"journal\": \"American journal of cancer research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — siRNA and recombinant protein treatments with specific pathway readouts, single lab\",\n      \"pmids\": [\"30906632\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"DKK1 promotes invasion and migration of hepatocellular carcinoma cells through a TGF-β1–dependent mechanism; knockdown of TGF-β1 negatively affected the DKK1 proinvasive effect; the canonical Wnt/β-catenin pathway was not responsible for the proinvasive effect as active β-catenin levels were unchanged upon DKK1 treatment.\",\n      \"method\": \"Recombinant DKK1 treatment, DKK1 siRNA knockdown, TGF-β1 siRNA knockdown, Boyden chamber invasion assay, zymography, MMP-2/MMP-9 Western blot, ELISA\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — reciprocal knockdown of DKK1 and TGF-β1 with functional assays, single lab\",\n      \"pmids\": [\"31568519\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"EGF receptor activation promotes DKK1 transcription in HCC via parallel MEK-ERK and PI3K-Akt pathways: ERK phosphorylates PKM2 at Ser37 promoting its nuclear translocation, and Akt phosphorylates p300 at Ser1834; nuclear PKM2 and p300 then cooperatively mediate phosphorylation and acetylation of histone H3 at the DKK1 promoter to synergistically enhance DKK1 transcription.\",\n      \"method\": \"Mutational analysis of PKM2-Ser37 and p300-Ser1834, nuclear fractionation, ChIP for histone H3 phosphorylation/acetylation at DKK1 promoter, MEK/PI3K inhibition, chemically-induced HCC rat model\",\n      \"journal\": \"Science signaling\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — site-directed mutagenesis of two kinase substrates combined with ChIP and in vivo validation, multiple orthogonal methods\",\n      \"pmids\": [\"33172955\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"1,25-dihydroxyvitamin D3 (1,25D3) promotes DKK1 expression in osteoblasts by inducing C/EBPβ, which directly binds the human DKK1 promoter; 1,25D3 also stimulates secretion of DKK1 from the endoplasmic reticulum to the extracellular space; blocking DKK1 attenuated calcified nodule formation in mineralized osteoblasts without affecting ALP activity or collagen synthesis, establishing a required role for DKK1 in osteoblast mineralization.\",\n      \"method\": \"C/EBPβ siRNA knockdown and overexpression, ChIP for C/EBPβ at DKK1 promoter, 1,25D3 treatment, DKK1 secretion/ER trafficking assay, DKK1 blocking antibody in mineralization assay\",\n      \"journal\": \"Cells\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Strong — ChIP of transcription factor at DKK1 promoter, complementary knockdown/overexpression, functional blocking experiment, single lab with multiple orthogonal methods\",\n      \"pmids\": [\"31963554\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"Under hypoxia, p38 kinase phosphorylates CREB driving its nuclear import to activate DKK1 transcription in myeloma cells; CREB recruits MMSET (a downstream target of HIF-1α induced by hypoxia), stabilizing HIF-1α protein and increasing H3K36me2 at the DKK1 promoter; combined CREB inhibition and hypoxia-activated prodrug reduced MM-induced bone destruction in vivo.\",\n      \"method\": \"p38 inhibition, CREB knockdown, MMSET knockdown, ChIP for H3K36me2 at DKK1 promoter, nuclear import assay, in vivo MM bone destruction model\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Strong — ChIP for specific histone mark at DKK1 promoter, kinase pathway inhibition, genetic knockdowns with in vivo validation\",\n      \"pmids\": [\"33420361\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"DKK1 suppresses WWP2 (an E3 ubiquitin ligase) expression via canonical Wnt/β-catenin signaling; loss of WWP2 stabilizes GLI2 (a Hedgehog transcription factor) by preventing its ubiquitination and proteasomal degradation, thereby activating Hedgehog signaling and promoting bortezomib resistance in multiple myeloma cells.\",\n      \"method\": \"WWP2 knockdown and overexpression, DKK1 manipulation, GLI2 ubiquitination assay, Hh pathway reporter, in vitro and in vivo bortezomib resistance assays\",\n      \"journal\": \"Carcinogenesis\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ubiquitination assay combined with pathway-specific reporters and in vivo validation, single lab\",\n      \"pmids\": [\"34546340\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"hAMSC-derived DKK-1 (along with IGFBP-3 and DKK-3) inhibits hepatic stellate cell activation by blocking the canonical Wnt/β-catenin signaling pathway; siRNA silencing of DKK-1 in hAMSCs reversed this inhibitory effect, attenuating the anti-fibrotic action; this was confirmed via GSK3β/β-catenin pathway assessment.\",\n      \"method\": \"hAMSC transplantation in CCl4-induced liver fibrosis mice, antibody array for secreted cytokines, siRNA knockdown of DKK-1/DKK-3/IGFBP-3, Western blot for Wnt/β-catenin components\",\n      \"journal\": \"Stem cell research & therapy\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — secretome array combined with siRNA epistasis validation in vitro and in vivo, single lab\",\n      \"pmids\": [\"35659360\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"DKK1 binding to CKAP4 is required for HCC cell proliferation; DKK1 lacking the CKAP4 binding region did not rescue phenotypes caused by DKK1 depletion; deletion of either DKK1 or CKAP4 inhibited HCC cell growth; anti-CKAP4 antibody inhibited HCC growth and showed enhanced antitumor effect when combined with lenvatinib.\",\n      \"method\": \"DKK1/CKAP4 deletion in HCC cells, domain-deletion rescue experiment, anti-CKAP4 antibody treatment, in vivo HCC tumor growth assay, co-treatment with lenvatinib\",\n      \"journal\": \"Cancer science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — domain-deletion rescue experiment establishes binding requirement, complemented by in vivo antibody experiments\",\n      \"pmids\": [\"36718957\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"DKK1 in prostate cancer cells promotes growth and migration independently of canonical Wnt signaling via upregulation of NF-κB/p65 signaling, inhibition of caspase-dependent apoptosis through downregulation of non-canonical Wnt/JNK signaling, and upregulation of EMT genes; DKK1 also inhibits osteoblast differentiation and promotes osteoclast activity by decreasing the OPG/RANKL ratio in the bone microenvironment.\",\n      \"method\": \"Stable DKK1 transduction in Probasco PCa cells, intratibial/intracardiac injection in nude mice, in vitro proliferation/migration assays, NF-κB/p65 and caspase Western blot, primary osteoblast/osteoclast co-culture assays, OPG/RANKL measurement\",\n      \"journal\": \"Cells\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — in vivo and in vitro with multiple signaling pathway readouts and bone cell functional assays\",\n      \"pmids\": [\"38067123\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"NR2F2 silencing in endothelial cells induces DKK1 production; co-silencing DKK1 and NR2F2 prevents NR2F2-loss-induced STAT and AKT activation and reverses endothelial-to-mesenchymal transition, establishing DKK1 as a downstream effector of NR2F2 loss that drives pathologic endothelial signaling.\",\n      \"method\": \"NR2F2 siRNA silencing, co-silencing of NR2F2 and DKK1, STAT/AKT phosphorylation Western blot, EndMT marker analysis, serum DKK1 ELISA in PAH patients\",\n      \"journal\": \"American journal of physiology. Lung cellular and molecular physiology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — co-silencing epistasis with multiple molecular readouts, single lab\",\n      \"pmids\": [\"37039367\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"DKK1 loss in endometrial stromal cells promotes endometrial fibrosis by suppressing autophagic flux through Wnt/β-catenin and PI3K/AKT/mTOR pathways, and by promoting secretion of IL-8 in exosomes that drives macrophage proliferation and macrophage-to-myofibroblast transition; rapamycin partially restored the fibrotic phenotype in DKK1 conditional knockout mice.\",\n      \"method\": \"DKK1 conditional knockout mice, DKK1 siRNA/overexpression in endometrial stromal cells, autophagic flux assay, exosome IL-8 measurement, rapamycin rescue experiment, immunohistochemistry for α-SMA/macrophages\",\n      \"journal\": \"Journal of translational medicine\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — conditional KO with in vitro mechanistic follow-up, rapamycin epistasis, single lab\",\n      \"pmids\": [\"38961399\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"DKK1 is a secreted glycoprotein that functions primarily as a canonical Wnt inhibitor by competing with Wnt ligands for binding to LRP5/6 co-receptors (facilitated by Kremen1/2 high-affinity receptors that internalize via clathrin-mediated endocytosis), thereby suppressing β-catenin/TCF transcription; its expression is directly activated by transcription factors OTX2 and Osterix at defined promoter elements, induced epigenetically by EGFR-driven PKM2/p300-mediated H3 phospho-acetylation and by hypoxia-driven CREB/MMSET H3K36me2, and repressed by CpG methylation; beyond canonical Wnt inhibition, DKK1 signals through a β-catenin-independent CKAP4 receptor to drive cancer cell proliferation, through AKT phosphorylation to promote tumor growth, via TGF-β1 to promote invasion, and through NF-κB/non-canonical Wnt/JNK to inhibit apoptosis; in bone, DKK1 from osteoblasts/osteocytes suppresses osteoblastogenesis while promoting osteoclast activity, and its upregulation by Sost/sclerostin constitutes a compensatory mechanism limiting Wnt-driven bone anabolism; in the immune microenvironment, stroma-derived DKK1 suppresses β-catenin in MDSCs to drive immune suppression, while in epithelial tissues DKK1 disrupts directional cell polarity by mislocalizing Cdc42 and displacing Par6 from the leading edge.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"DKK1 is a secreted glycoprotein that acts as a context-dependent antagonist of canonical Wnt/\\u03b2-catenin signaling, patterning embryonic axes and tuning Wnt output in bone, cartilage, vasculature, immune cells, and epithelia [#0, #5, #15]. In development it is expressed in the Spemann organizer and prechordal plate, where its secreted Wnt-antagonist activity patterns the anterior nervous system and axial mesendoderm; this expression is driven directly by OTX2 binding the H1 regulatory region and is required, together with Wnt restraint, for anterior head and peri-cloacal anorectal/genitourinary morphogenesis [#0, #14, #17]. High-affinity Kremen receptors clear DKK1 from the cell surface through clathrin- and AP-2-dependent endocytosis governed by an atypical Kremen1 dileucine motif [#12]. In bone, osteoblast/osteocyte-derived DKK1 suppresses Wnt-driven osteoblast differentiation and new bone formation while promoting osteoclast activity, and its conditional loss is buffered by compensatory upregulation of sclerostin, such that combined Dkk1/Sost ablation yields synergistic anabolic bone gain; this axis underlies inflammatory bone erosion, periodontal bone loss, and protection of cartilage in osteoarthritis [#5, #6, #22, #24, #15]. DKK1 transcription is regulated by Osterix and C/EBP\\u03b2 at the proximal promoter, by epigenetic activation through CBX7/p300 histone acetylation, EGFR-driven nuclear PKM2/p300-mediated H3 phospho-acetylation, and hypoxia-driven CREB/MMSET H3K36me2, and is silenced by CpG promoter hypermethylation in colon cancer [#11, #28, #19, #27, #29, #2]. Beyond canonical Wnt inhibition, DKK1 drives \\u03b2-catenin-independent oncogenic signaling: it binds CKAP4 to sustain hepatocellular carcinoma proliferation, signals through AKT and TGF-\\u03b21 to promote tumor growth and invasion, and through NF-\\u03baB and non-canonical Wnt/JNK to promote prostate cancer growth and suppress apoptosis [#32, #25, #26, #33]. In the tumor microenvironment, stroma-derived DKK1 suppresses \\u03b2-catenin in myeloid-derived suppressor cells to enforce immune suppression, and in migrating epithelial cells it disrupts directional polarity by mislocalizing Cdc42 and displacing Par6 from the leading edge [#21, #4].\",\n  \"teleology\": [\n    {\n      \"year\": 1999,\n      \"claim\": \"Establishing DKK1 as a secreted Wnt antagonist that patterns the anterior nervous system answered what its core embryonic activity is and where it acts.\",\n      \"evidence\": \"Ectopic mRNA expression and genetic epistasis across zebrafish mutants with in situ hybridization\",\n      \"pmids\": [\"10625541\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Receptor identity at the time undefined\", \"Did not address mammalian organogenesis roles\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Discovery of CpG promoter hypermethylation silencing DKK1 in colon cancer, with Wnt-independent tumor-suppressor effects upon re-expression, revealed both an epigenetic control mode and a \\u03b2-catenin-independent function.\",\n      \"evidence\": \"Methylation-specific PCR, demethylation, colony/xenograft assays and TCF reporter in colon cancer lines\",\n      \"pmids\": [\"16491118\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism of Wnt-independent suppression not defined\", \"Receptor mediating the effect unknown\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Linking extracellular DKK1 to mislocalized Cdc42 and Par6 displacement explained how it disrupts directional epithelial cell migration.\",\n      \"evidence\": \"Wound healing with reciprocal recombinant treatment/siRNA and immunofluorescence of polarity machinery in intestinal epithelial cells\",\n      \"pmids\": [\"19776352\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Receptor coupling DKK1 to Cdc42 not identified\", \"Relationship to canonical Wnt not resolved\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"In vivo neutralization in inflammatory and metastatic models established DKK1 as a driver of pathological bone remodeling acting on both osteoblasts and osteoclasts, and through canonical and non-canonical (JNK) Wnt arms.\",\n      \"evidence\": \"Anti-Dkk-1 antibody in TNFtg mice, prostate cancer bone metastasis models, histomorphometry, TCF reporter, phospho-JNK blots\",\n      \"pmids\": [\"20858621\", \"19304568\", \"20957670\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Cell-intrinsic vs paracrine contributions not separated\", \"Direct receptors in osteoclast lineage unclear\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Identifying Osterix as a direct activator and Kremen-mediated clathrin endocytosis defined transcriptional control and surface clearance of DKK1.\",\n      \"evidence\": \"ChIP, promoter deletion luciferase, Osx-null calvaria; Kremen1 dileucine mutagenesis with AP-2 siRNA and pitstop 2\",\n      \"pmids\": [\"22459449\", \"23251700\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How endocytosis quantitatively tunes Wnt inhibition unclear\", \"Other promoter inputs not mapped\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Demonstrating DKK1 protection of cartilage and angiogenic regulation expanded its role into joint disease and vascular biology.\",\n      \"evidence\": \"Chondrocyte transgenic/adenoviral OA models with Wnt-3a catabolic gene assays; synovial fibroblast HIF-1\\u03b1/angiogenic axis and tumor vascular models\",\n      \"pmids\": [\"22488261\", \"22736200\", \"24091497\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Context-dependent pro- vs anti-angiogenic switch mechanism unclear\", \"Distinct from DKK2 opposing role unexplained\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"OTX2 binding the H1 element and conditional Dkk1 deletion in peri-cloacal mesenchyme established direct upstream control and a developmental requirement in head and anorectal/genitourinary morphogenesis.\",\n      \"evidence\": \"Conditional Otx2/Dkk1 knockouts, ChIP, luciferase, compound-mutant epistasis, BrdU proliferation\",\n      \"pmids\": [\"25231759\", \"24479159\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Cross-tissue generalization of OTX2 control untested\", \"Other transcriptional inputs in non-neural tissues unmapped\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Identifying CBX7/p300 histone acetylation as a DKK1 activator and CA9 as a binding partner broadened the regulatory and interaction landscape.\",\n      \"evidence\": \"ChIP for promoter acetylation, CBX7-p300 co-IP, stem-cell marker rescue; CA9 co-IP and domain mapping with mTOR/angiogenesis readouts\",\n      \"pmids\": [\"25351982\", \"22430125\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"CA9 interaction is single-lab without reciprocal validation in vivo\", \"Physiological significance of CA9 binding unclear\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Showing stroma-derived DKK1 suppresses \\u03b2-catenin in MDSCs answered how it contributes to tumor immune suppression beyond tumor-cell-autonomous effects.\",\n      \"evidence\": \"Antibody neutralization, myeloid \\u03b2-catenin conditional KO epistasis, MDSC depletion, recombinant DKK1 in mouse and human cells\",\n      \"pmids\": [\"27045006\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Receptor on MDSCs not identified\", \"Breadth across tumor types not established\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Conditional Dkk1/Sost double deletion revealed sclerostin as the compensatory mechanism limiting the bone phenotype of DKK1 loss, explaining why single inhibition is buffered.\",\n      \"evidence\": \"Bone-specific Dkk1 KO, Sost KO epistasis, dual antibody co-treatment, \\u03bcCT/DXA/biomechanics\",\n      \"pmids\": [\"29875318\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular basis of Sost upregulation upon DKK1 loss undefined\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Dissection of Wnt-axis-independent oncogenic signaling through AKT and TGF-\\u03b21 clarified how DKK1 promotes proliferation and invasion without engaging \\u03b2-catenin.\",\n      \"evidence\": \"siRNA knockdown and recombinant treatment in esophageal and hepatocellular carcinoma cells with AKT/\\u03b2-catenin and TGF-\\u03b21 reciprocal readouts\",\n      \"pmids\": [\"30906632\", \"31568519\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Receptor linking DKK1 to AKT/TGF-\\u03b21 not resolved in these studies\", \"Single-lab, single-line findings\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Mapping EGFR-driven nuclear PKM2/p300 H3 phospho-acetylation and C/EBP\\u03b2 induction defined signal-responsive transcriptional activation of DKK1.\",\n      \"evidence\": \"Site-directed mutagenesis of PKM2-Ser37/p300-Ser1834, ChIP at DKK1 promoter, in vivo HCC; C/EBP\\u03b2 ChIP and 1,25D3 secretion/mineralization assays\",\n      \"pmids\": [\"33172955\", \"31963554\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Integration of multiple promoter inputs in vivo unclear\", \"Cell-type specificity of each pathway not delineated\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Hypoxia-driven CREB/MMSET H3K36me2 and DKK1-WWP2-GLI2 crosstalk linked DKK1 induction and downstream Hedgehog activation to myeloma bone disease and drug resistance.\",\n      \"evidence\": \"p38/CREB/MMSET knockdown, ChIP for H3K36me2; WWP2/GLI2 ubiquitination assays and bortezomib resistance models\",\n      \"pmids\": [\"33420361\", \"34546340\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"WWP2-GLI2 axis single-lab without independent confirmation\", \"Generalizability beyond myeloma untested\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Identifying CKAP4 as a required receptor for DKK1-driven HCC proliferation and NF-\\u03baB/JNK signaling in prostate cancer pinned down \\u03b2-catenin-independent receptor mechanisms.\",\n      \"evidence\": \"DKK1/CKAP4 deletion and domain-deletion rescue, anti-CKAP4 antibody with lenvatinib; prostate cancer DKK1 transduction with NF-\\u03baB/caspase and OPG/RANKL assays\",\n      \"pmids\": [\"36718957\", \"38067123\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether CKAP4 mediates AKT/TGF-\\u03b21 effects in other tumors untested\", \"Structural basis of receptor selectivity unclear\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Defining DKK1 loss as a driver of endometrial fibrosis via autophagy suppression and exosomal IL-8 extended its role into tissue fibrosis and stromal-immune crosstalk.\",\n      \"evidence\": \"DKK1 conditional KO mice, stromal cell siRNA/overexpression, autophagic flux and exosome IL-8 assays, rapamycin rescue\",\n      \"pmids\": [\"38961399\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single-lab study\", \"Receptor/pathway selectivity in stromal cells not fully resolved\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"The receptor logic distinguishing canonical Wnt-inhibitory DKK1 (via LRP5/6-Kremen) from \\u03b2-catenin-independent signaling (CKAP4, AKT, NF-\\u03baB/JNK, TGF-\\u03b21) and how cells select between these outputs remains unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No unifying model linking receptor engagement to downstream pathway choice\", \"Structural determinants of partner selection not defined\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [0, 5, 15]},\n      {\"term_id\": \"GO:0048018\", \"supporting_discovery_ids\": [32, 16]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005576\", \"supporting_discovery_ids\": [0, 4, 28]},\n      {\"term_id\": \"GO:0005783\", \"supporting_discovery_ids\": [28]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [0, 7, 33]},\n      {\"term_id\": \"R-HSA-1266738\", \"supporting_discovery_ids\": [0, 14, 17]},\n      {\"term_id\": \"R-HSA-1643685\", \"supporting_discovery_ids\": [2, 21, 32]},\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [21]},\n      {\"term_id\": \"R-HSA-74160\", \"supporting_discovery_ids\": [11, 14, 27, 28, 29]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\"LRP5\", \"LRP6\", \"KREMEN1\", \"CKAP4\", \"CA9\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":7,"faith_total":7,"faith_pct":100.0}}